<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK500456" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK500456/" /><meta name="ncbi_pagename" content="Maturity-Onset Diabetes of the Young Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Maturity-Onset Diabetes of the Young Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Maturity-Onset Diabetes of the Young Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/05/24" /><meta name="citation_author" content="Rochelle Naylor" /><meta name="citation_author" content="Amy Knight Johnson" /><meta name="citation_author" content="Daniela del Gaudio" /><meta name="citation_pmid" content="29792621" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK500456/" /><meta name="citation_keywords" content="MODY Overview" /><meta name="citation_keywords" content="MODY Overview" /><meta name="citation_keywords" content="ATP-binding cassette sub-family C member 8" /><meta name="citation_keywords" content="ATP-sensitive inward rectifier potassium channel 11" /><meta name="citation_keywords" content="Bile salt-activated lipase" /><meta name="citation_keywords" content="DCC-interacting protein 13-alpha" /><meta name="citation_keywords" content="Hepatocyte nuclear factor 1-alpha" /><meta name="citation_keywords" content="Hepatocyte nuclear factor 1-beta" /><meta name="citation_keywords" content="Hepatocyte nuclear factor 4-alpha" /><meta name="citation_keywords" content="Hexokinase-4" /><meta name="citation_keywords" content="Insulin" /><meta name="citation_keywords" content="Krueppel-like factor 11" /><meta name="citation_keywords" content="Neurogenic differentiation factor 1" /><meta name="citation_keywords" content="Paired box protein Pax-4" /><meta name="citation_keywords" content="Pancreas/duodenum homeobox protein 1" /><meta name="citation_keywords" content="Tyrosine-protein kinase Blk" /><meta name="citation_keywords" content="ABCC8" /><meta name="citation_keywords" content="APPL1" /><meta name="citation_keywords" content="BLK" /><meta name="citation_keywords" content="CEL" /><meta name="citation_keywords" content="GCK" /><meta name="citation_keywords" content="HNF1A" /><meta name="citation_keywords" content="HNF1B" /><meta name="citation_keywords" content="HNF4A" /><meta name="citation_keywords" content="INS" /><meta name="citation_keywords" content="KCNJ11" /><meta name="citation_keywords" content="KLF11" /><meta name="citation_keywords" content="NEUROD1" /><meta name="citation_keywords" content="PAX4" /><meta name="citation_keywords" content="PDX1" /><meta name="citation_keywords" content="Maturity Onset Diabetes of the Young" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Maturity-Onset Diabetes of the Young Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Rochelle Naylor" /><meta name="DC.Contributor" content="Amy Knight Johnson" /><meta name="DC.Contributor" content="Daniela del Gaudio" /><meta name="DC.Date" content="2018/05/24" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK500456/" /><meta name="description" content="The purpose of this overview is to increase the awareness of clinicians regarding maturity-onset diabetes of the young (MODY) and its genetic causes and management." /><meta name="og:title" content="Maturity-Onset Diabetes of the Young Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="The purpose of this overview is to increase the awareness of clinicians regarding maturity-onset diabetes of the young (MODY) and its genetic causes and management." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK500456/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mody-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK500456/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A62EBE041A62100000000075002C3.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK500456_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK500456_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mss/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mkks/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK500456_"><span class="title" itemprop="name">Maturity-Onset Diabetes of the Young Overview</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: MODY Overview</div><p class="contrib-group"><span itemprop="author">Rochelle Naylor</span>, MD, <span itemprop="author">Amy Knight Johnson</span>, MS, CGC, and <span itemprop="author">Daniela del Gaudio</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK500456_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK500456_ai__"><div class="contrib half_rhythm"><span itemprop="author">Rochelle Naylor</span>, MD<div class="affiliation small">Departments of Pediatrics and Medicine<br />University of Chicago<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu.dsb@rolyanr" class="oemail">ude.ogacihcu.dsb@rolyanr</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Amy Knight Johnson</span>, MS, CGC<div class="affiliation small">Department of Human Genetics<br />University of Chicago<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu.dsb@nosnhojthginka" class="oemail">ude.ogacihcu.dsb@nosnhojthginka</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Daniela del Gaudio</span>, PhD<div class="affiliation small">Department of Human Genetics<br />University of Chicago<br />Chicago, Illinois<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.ogacihcu.dsb@oiduagledd" class="oemail">ude.ogacihcu.dsb@oiduagledd</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">May 24, 2018</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mody-ov.Summary" itemprop="description"><h2 id="_mody-ov_Summary_">Summary</h2><p>The purpose of this overview is to increase the awareness of clinicians regarding maturity-onset diabetes of the young (MODY) and its genetic causes and management.</p><p>The following are the goals of this overview:</p><div><h4 class="inline">Goal 1.</h4><p>Describe the <a href="#mody-ov._escape__1_Clinical_Characterist">clinical characteristics</a> of MODY.</p></div><div><h4 class="inline">Goal 2.</h4><p>Review the <a href="#mody-ov._escape__2_Genetic_Causes_of_MOD">genetic causes</a> of MODY.</p></div><div><h4 class="inline">Goal 3.</h4><p>Provide an <a href="#mody-ov._escape__3_Evaluation_Strategy_t">evaluation strategy</a> to identify the genetic cause of MODY in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (when possible).</p></div><div><h4 class="inline">Goal 4.</h4><p>Inform (when possible) <a href="#mody-ov._escape__4_Management_of_MODY_Ba">medical management</a> of MODY based on genetic cause.</p></div><div><h4 class="inline">Goal 5.</h4><p>Inform <a href="#mody-ov._escape__5_Risk_Assessment_and_S">risk assessment and surveillance</a> of at-risk relatives for early detection and treatment of MODY.</p></div></div><div id="mody-ov._escape__1_Clinical_Characterist"><h2 id="_mody-ov__escape__1_Clinical_Characterist_">1. Clinical Characteristics of MODY</h2><p>Maturity-onset diabetes of the young (MODY) is a group of inherited disorders of non-autoimmune diabetes mellitus which usually present in adolescence or young adulthood.</p><p>A clinical diagnosis of MODY can be suspected in individuals with:</p><ul><li class="half_rhythm"><div>Early-onset diabetes in adolescence or young adulthood (typically age &#x0003c;35 years);</div></li><li class="half_rhythm"><div>Features atypical for type 1 diabetes mellitus including the following:</div><ul><li class="half_rhythm"><div>Absence of pancreatic islet autoantibodies [<a class="bk_pop" href="#mody-ov.REF.mcdonald.2011a.1028">McDonald et al 2011a</a>]</div></li><li class="half_rhythm"><div>Evidence of endogenous insulin production beyond the honeymoon period (i.e., 3-5 years after the onset of diabetes)</div></li><li class="half_rhythm"><div>Measurable C-peptide in the presence of hyperglycemia (C-peptide &#x02265;0.60 ng/mL or 0.2 nmol/L) [<a class="bk_pop" href="#mody-ov.REF.besser.2011.607">Besser et al 2011</a>, <a class="bk_pop" href="#mody-ov.REF.ludvigsson.2012.45">Ludvigsson et al 2012</a>]</div></li><li class="half_rhythm"><div>Low insulin requirement for treatment (i.e., &#x0003c;0.5 U/kg/d)</div></li><li class="half_rhythm"><div>Lack of ketoacidosis when insulin is omitted from treatment</div></li></ul></li><li class="half_rhythm"><div>Features atypical for type 2 diabetes mellitus including the following:</div><ul><li class="half_rhythm"><div>Onset of diabetes before age 45 years</div></li><li class="half_rhythm"><div>Lack of significant obesity</div></li><li class="half_rhythm"><div>Lack of acanthosis nigricans</div></li><li class="half_rhythm"><div>Normal triglyceride levels and/or normal or elevated high-density lipoprotein cholesterol (HDL-C)</div></li></ul></li><li class="half_rhythm"><div>Mild, stable fasting hyperglycemia that does not progress or respond appreciably to pharmacologic therapy</div></li><li class="half_rhythm"><div>Extreme sensitivity to sulfonylureas</div></li><li class="half_rhythm"><div>Extrapancreatic features (e.g., renal, hepatic, gastrointestinal)</div></li><li class="half_rhythm"><div>A personal history or family history of neonatal diabetes or neonatal hypoglycemia</div></li><li class="half_rhythm"><div>A family history of diabetes consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance that contrasts with type 1 diabetes and type 2 diabetes in the following ways:</div><ul><li class="half_rhythm"><div>Type 1 diabetes can run in families but is often <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a>: only 2%-6% of individuals with type 1 diabetes have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent [<a class="bk_pop" href="#mody-ov.REF.harjutsalo.2010.210">Harjutsalo et al 2010</a>].</div></li><li class="half_rhythm"><div>Type 2 diabetes often runs in families: shared risk alleles and shared environment can lead to occurrence of type 2 diabetes in multiple family members. Family history that helps distinguish between type 2 diabetes and MODY are onset of diabetes after age 45 years in association with obesity (type 2 diabetes) versus onset of diabetes before age 35 years and lack of obesity (MODY).</div></li></ul></li></ul><p>Note: (1) A clinical prediction tool that can be used to calculate an individual's probability of having MODY also provides a rational approach to <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> [<a class="bk_pop" href="#mody-ov.REF.shields.2012.1265">Shields et al 2012</a>, <a class="bk_pop" href="#mody-ov.REF.thomas.2016.332">Thomas et al 2016</a>]. This tool (click <a href="https://www.diabetesgenes.org/mody-probability-calculator/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">here</a>), which applies only to individuals younger than age 35 years, was developed in a cohort of white Europeans. (2) Genetic risk scores have been developed to distinguish type 1 diabetes from monogenic diabetes and from type 2 diabetes. To date these scores have been studied in fairly homogeneous (i.e., white European) populations [<a class="bk_pop" href="#mody-ov.REF.patel.2016.2094">Patel et al 2016</a>].</p><p>Prevalence of MODY. Although estimates of prevalence vary by country, between children and adults, and by method of ascertainment, MODY is thought to account for at least 1%-3% of all diabetes [<a class="bk_pop" href="#mody-ov.REF.shields.2010.2504">Shields et al 2010</a>, <a class="bk_pop" href="#mody-ov.REF.pihoker.2013.4055">Pihoker et al 2013</a>, <a class="bk_pop" href="#mody-ov.REF.shepherd.2016.1879">Shepherd et al 2016</a>].</p><p>The prevalence of MODY in racial and ethnic minorities may be underrepresented as many individuals with MODY remain undiagnosed [<a class="bk_pop" href="#mody-ov.REF.shields.2010.2504">Shields et al 2010</a>] and studies to date have largely involved white populations.</p></div><div id="mody-ov._escape__2_Genetic_Causes_of_MOD"><h2 id="_mody-ov__escape__2_Genetic_Causes_of_MOD_">2. Genetic Causes of MODY</h2><p>To date it has been proposed that pathogenic variants in at least 14 genes cause MODY. The genes and associated clinical features are summarized in <a class="figpopup" href="/books/NBK500456/table/mody-ov.T.maturityonset_diabetes_of_the/?report=objectonly" target="object" rid-figpopup="figmodyovTmaturityonsetdiabetesofthe" rid-ob="figobmodyovTmaturityonsetdiabetesofthe">Table 1</a>.</p><p>The four most common causes of MODY are the following:</p><ul><li class="half_rhythm"><div><i>GCK</i>-MODY (MODY2) and <i>HNF1A</i>-MODY (MODY3), each accounting for 30%-60% of all MODY. The prevalence of <i>GCK</i>-MODY has been estimated at 1:1,000 individuals [<a class="bk_pop" href="#mody-ov.REF.chakera.2014.1230">Chakera et al 2014</a>]; however, among all causes of MODY, the prevalence of <i>GCK</i>-MODY is higher in some countries (United States, Germany, Italy, France, and Spain) [<a class="bk_pop" href="#mody-ov.REF.estalella.2007.538">Estalella et al 2007</a>, <a class="bk_pop" href="#mody-ov.REF.schober.2009.466">Schober et al 2009</a>, <a class="bk_pop" href="#mody-ov.REF.carmody.2016.703">Carmody et al 2016</a>] most likely due to biased ascertainment of children compared to adults.</div></li><li class="half_rhythm"><div><i>HNF4A</i>-MODY (MODY1) and <i>HNF1B-</i>MODY (MODY5), together accounting for about 10% of all MODY</div></li></ul><p>Approximately 20% of all MODY has been attributed to pathogenic variants in ten other genes &#x02013; some of which were designated before the availability of large-scale genetic testing and thus may be incorrectly associated with MODY. Molecular genetic testing of large numbers of individuals with possible MODY as well as other investigations (e.g., functional studies and/or <a class="def" href="/books/n/gene/glossary/def-item/segregation/">segregation</a> of variants with the disease) are needed to determine the significance of variants previously inferred to be pathogenic based on other methods.</p><p>A portion of MODY may be caused by pathogenic variants in yet-to-be-identified genes or complex molecular alterations in the known MODY-related genes that were not detected by previous genetic testing methods [<a class="bk_pop" href="#mody-ov.REF.ellard.2008.546">Ellard et al 2008</a>].</p><div id="mody-ov.T.maturityonset_diabetes_of_the" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Maturity-Onset Diabetes of the Young (MODY): Genes and Associated Clinical Features</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK500456/table/mody-ov.T.maturityonset_diabetes_of_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mody-ov.T.maturityonset_diabetes_of_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene<br />(Locus<br />Name)</th><th id="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of All<br />MODY</th><th id="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features</th><th id="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency of Microvascular Complications</th><th id="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References /<br />Selected OMIM Links</th></tr></thead><tbody><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCC8</i>&#x000a0;<sup>1,</sup>&#x000a0;<sup>2</sup><br />(MODY12)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar to <i>HNF1A</i>- &#x00026; <i>HNF4A</i>-MODY&#x000a0;<sup>3</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.bowman.2012.123">Bowman et al [2012]</a> / <a href="https://omim.org/entry/600509" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600509</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APPL1</i><br />(MODY14)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>4</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overweight/obesity in some</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.prudente.2015.177">Prudente et al [2015]</a> / <a href="https://omim.org/entry/616511" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616511</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLK</i><br />(MODY11)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>5</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overweight/obesity in some</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.kim.2004.1375">Kim et al [2004]</a>, <a class="bk_pop" href="#mody-ov.REF.borowiec.2009.14460">Borowiec et al [2009]</a> / <a href="https://omim.org/entry/613375" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613375</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CEL</i><br />(MODY8)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>6</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Pancreatic atrophy &#x02192; exocrine pancreatic insufficiency</div></li><li class="half_rhythm"><div>Fibrosis &#x00026; lipomatosis &#x02192; diabetes</div></li></ul></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.raeder.2006.54">Raeder et al [2006]</a>, <a class="bk_pop" href="#mody-ov.REF.johansson.2011.34593">Johansson et al [2011]</a> / <a href="https://omim.org/entry/609812" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609812</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCK</i><br />(MODY2)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%-50%&#x000a0;<sup>7,&#x000a0;8</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Stable, mild fasting hyperglycemia at birth</div></li><li class="half_rhythm"><div>Typically asymptomatic; diagnosis often incidental</div></li></ul></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>9</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.froguel.1993.697">Froguel et al [1993]</a>, <a class="bk_pop" href="#mody-ov.REF.pearson.2001.s101">Pearson et al [2001]</a> / <a href="https://omim.org/entry/125851" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">125851</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HNF1A</i>&#x000a0;<sup>3</sup><br />(MODY3)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%-65%&#x000a0;<sup>7,&#x000a0;10,&#x000a0;11</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Transient neonatal hyperinsulinemic hypoglycemia in some</div></li><li class="half_rhythm"><div>Progressive insulin secretory defect</div></li><li class="half_rhythm"><div>OGTT frequently needed to make an early diagnosis</div></li><li class="half_rhythm"><div>Renal glycosuria</div></li></ul></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common&#x000a0;<sup>12</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.stride.2005.1751">Stride et al [2005]</a> / <a href="https://omim.org/entry/600496" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">600496</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HNF1B</i><br />(MODY5)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5%&#x000a0;<sup>13</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>IUGR</div></li><li class="half_rhythm"><div>Renal anomalies</div></li><li class="half_rhythm"><div>Urogenital tract anomalies</div></li><li class="half_rhythm"><div>Pancreatic hypoplasia</div></li></ul></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common&#x000a0;<sup>12</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.montoli.2002.397">Montoli et al [2002]</a>, <a class="bk_pop" href="#mody-ov.REF.bellann_chantelot.2004.510">Bellann&#x000e9;-Chantelot et al [2004]</a>, <a class="bk_pop" href="#mody-ov.REF.ulinski.2006.497">Ulinski et al [2006]</a>, <a class="bk_pop" href="#mody-ov.REF.faguer.2011.768">Faguer et al [2011]</a> / <a href="https://omim.org/entry/137920" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">137920</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HNF4A</i>&#x000a0;<sup>2</sup><br />(MODY1)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5%-10%&#x000a0;<sup>14</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Birth weight &#x0003e;800 g above normal</div></li><li class="half_rhythm"><div>Transient neonatal hyperinsulinemic hypoglycemia common&#x000a0;<sup>15</sup></div></li><li class="half_rhythm"><div>Progressive insulin secretory defect</div></li></ul></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Common&#x000a0;<sup>12</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.fajans.2001.971">Fajans et al [2001]</a>, <a class="bk_pop" href="#mody-ov.REF.pearson.2005.878">Pearson et al [2005]</a>, <a class="bk_pop" href="#mody-ov.REF.pearson.2007.e118">Pearson et al [2007]</a>, <a class="bk_pop" href="#mody-ov.REF.shields.2010.2504">Shields et al [2010]</a> / <a href="https://omim.org/entry/125850" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">125850</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>INS</i>&#x000a0;<sup>1</sup><br />(MODY10)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.edghill.2008a.1034">Edghill et al [2008a]</a>, <a class="bk_pop" href="#mody-ov.REF.meur.2010.653">Meur et al [2010]</a> / <a href="https://omim.org/entry/613370" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613370</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNJ11</i>&#x000a0;<sup>1,&#x000a0;2</sup><br />(MODY13)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar to <i>HNF1A</i>-MODY &#x00026; <i>HNF4A</i>-MODY&#x000a0;<sup>3</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.bonnefond.2012.e37423">Bonnefond et al [2012]</a>, <a class="bk_pop" href="#mody-ov.REF.liu.2013.2609">Liu et al [2013]</a> / <a href="https://omim.org/entry/616329" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616329</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KLF11</i><br />(MODY7)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>5</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.neve.2005.4807">Neve et al [2005]</a>, <a class="bk_pop" href="#mody-ov.REF.fernandezzapico.2009.36482">Fernandez-Zapico et al [2009]</a> / <a href="https://omim.org/entry/610508" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610508</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NEUROD1</i><br />(MODY6)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>5</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overweight/obesity in some</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.malecki.1999.323">Malecki et al [1999]</a>, <a class="bk_pop" href="#mody-ov.REF.kristinsson.2001.2098">Kristinsson et al [2001]</a> / <a href="https://omim.org/entry/606394" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606394</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAX4</i><br />(MODY9)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;1%&#x000a0;<sup>5</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.mauvaisjarvis.2004.3151">Mauvais-Jarvis et al [2004]</a>, <a class="bk_pop" href="#mody-ov.REF.plengvidhya.2007.2821">Plengvidhya et al [2007]</a> / <a href="https://omim.org/entry/612225" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">612225</a></td></tr><tr><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDX1</i>&#x000a0;<sup>1</sup><br />(MODY4)</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>5</sup></td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Overweight/obesity in some</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_mody-ov.T.maturityonset_diabetes_of_the_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.wright.1993.607">Wright et al [1993]</a>, <a class="bk_pop" href="#mody-ov.REF.stoffers.1997.138">Stoffers et al [1997]</a>, <a class="bk_pop" href="#mody-ov.REF.fajans.2010.7">Fajans et al [2010]</a> / <a href="https://omim.org/entry/606392" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606392</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">IUGR = intrauterine growth restriction; OGTT = oral glucose tolerance test</p></div></dd><dt>1. </dt><dd><div id="mody-ov.TF.1.1"><p class="no_margin">Pathogenic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are also associated with <a href="/books/n/gene/dmn/">permanent neonatal diabetes mellitus</a>.</p></div></dd><dt>2. </dt><dd><div id="mody-ov.TF.1.2"><p class="no_margin">Pathogenic variants in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> are also associated with <a href="/books/n/gene/hi/">familial hyperinsulinism</a>.</p></div></dd><dt>3. </dt><dd><div id="mody-ov.TF.1.3"><p class="no_margin">Should be considered in patients responsive to sulfonylurea who test negative for <i>HNF1A</i>-MODY and <i>HNF4A</i>-MODY</p></div></dd><dt>4. </dt><dd><div id="mody-ov.TF.1.4"><p class="no_margin">Two <i>APPL1</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants reported</p></div></dd><dt>5. </dt><dd><div id="mody-ov.TF.1.5"><p class="no_margin">Some variants in <i>BLK</i>, <i>KLF11</i>, <i>NEUROD1</i>, <i>PAX4</i>, and <i>PDX1</i> reported in the Human Gene Mutation Database (HGMD) as pathogenic are present in the <a href="http://exac.broadinstitute.org/about" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Exome Aggregation Consortium</a> (ExAC) Database and in the <a href="http://gnomad.broadinstitute.org/about" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Genome Aggregation Database</a> (gnomAD) at population frequencies that are not consistent with their potential clinical significance. Additional studies are necessary to better understand the association of variants in these genes with MODY.</p></div></dd><dt>6. </dt><dd><div id="mody-ov.TF.1.6"><p class="no_margin">One individual had a large <i>CEL</i> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> (429 nucleotides) [<a class="bk_pop" href="#mody-ov.REF.ellard.2013.1958">Ellard et al 2013</a>].</p></div></dd><dt>7. </dt><dd><div id="mody-ov.TF.1.7"><p class="no_margin">Depending on the population studied</p></div></dd><dt>8. </dt><dd><div id="mody-ov.TF.1.8"><p class="no_margin">~1.8% of <i>GCK</i>-MODY is associated with whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions [<a class="bk_pop" href="#mody-ov.REF.garin.2008.873">Garin et al 2008</a>].</p></div></dd><dt>9. </dt><dd><div id="mody-ov.TF.1.9"><p class="no_margin"><a class="bk_pop" href="#mody-ov.REF.steele.2014.279">Steele et al [2014]</a></p></div></dd><dt>10. </dt><dd><div id="mody-ov.TF.1.10"><p class="no_margin"><a class="bk_pop" href="#mody-ov.REF.frayling.1997.720">Frayling et al [1997]</a>, <a class="bk_pop" href="#mody-ov.REF.costa.2000.380">Costa et al [2000]</a>, <a class="bk_pop" href="#mody-ov.REF.gragnoli.2001.1326">Gragnoli et al [2001]</a>, <a class="bk_pop" href="#mody-ov.REF.xu.2005.422">Xu et al [2005]</a>, <a class="bk_pop" href="#mody-ov.REF.pihoker.2013.4055">Pihoker et al [2013]</a></p></div></dd><dt>11. </dt><dd><div id="mody-ov.TF.1.11"><p class="no_margin">~1.2% of <i>HNF1A</i>-MODY is associated with whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions [<a class="bk_pop" href="#mody-ov.REF.colclough.2013.669">Colclough et al 2013</a>].</p></div></dd><dt>12. </dt><dd><div id="mody-ov.TF.1.12"><p class="no_margin">Related to overall glycemic control [<a class="bk_pop" href="#mody-ov.REF.bacon.2016a.965">Bacon et al 2016a</a>, <a class="bk_pop" href="#mody-ov.REF.bacon.2016b.976">Bacon et al 2016b</a>]</p></div></dd><dt>13. </dt><dd><div id="mody-ov.TF.1.13"><p class="no_margin">~33% of <i>HNF1B</i>-MODY is associated with whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions [<a class="bk_pop" href="#mody-ov.REF.bellann_chantelot.2005.3126">Bellann&#x000e9;-Chantelot et al 2005</a>].</p></div></dd><dt>14. </dt><dd><div id="mody-ov.TF.1.14"><p class="no_margin">~1.9% of <i>HNF4A</i>-MODY is associated with whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions [<a class="bk_pop" href="#mody-ov.REF.colclough.2013.669">Colclough et al 2013</a>].</p></div></dd><dt>15. </dt><dd><div id="mody-ov.TF.1.15"><p class="no_margin">Individuals with <i>HNF4A-</i>MODY may also have reduced levels of lipoprotein A1, lipoprotein A2, and HDL cholesterol and increased levels of LDL-cholesterol, similar to the lipid profiles seen in type 2 diabetes mellitus [<a class="bk_pop" href="#mody-ov.REF.pearson.2005.878">Pearson et al 2005</a>].</p></div></dd></dl></div></div></div><p><b><i>GCK-</i>MODY (MODY2)</b> is characterized by mild, stable fasting hyperglycemia (5.5-8.0 mmol/L; 99-144 mg/dL) present at birth. Beta-cell function shows minimal deterioration with increasing age (as in the general population). Affected individuals are generally asymptomatic and the hyperglycemia is often discovered during routine medical examinations, such as in pregnancy or family screening when MODY is suspected. Diabetes-related complications are extremely uncommon.</p><p><b><i>HNF1A-</i>MODY (MODY3)</b> is associated with onset of diabetes in late adolescence or early adulthood. Typically in childhood or early adolescence, glucose tolerance is normal [<a class="bk_pop" href="#mody-ov.REF.lorini.2009.1864">Lorini et al 2009</a>]. However, prior to developing overt diabetes, <i>HNF1A</i> heterozygotes have marked progressive &#x003b2;-cell dysfunction, increased insulin sensitivity, and glycosuria [<a class="bk_pop" href="#mody-ov.REF.stride.2005.1751">Stride et al 2005</a>]. Oral glucose tolerance tests in early stages tend to show a very large glucose increment, usually &#x0003e;90 mg/dL [<a class="bk_pop" href="#mody-ov.REF.stride.2002.207">Stride &#x00026; Hattersley 2002</a>].</p><p>Penetrance in <i>HNF1A-</i>MODY is high: 63% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals develop diabetes by age 25 years, 78.6% by age 35 years, and 95.5% by age 55 years [<a class="bk_pop" href="#mody-ov.REF.shepherd.2001.417">Shepherd et al 2001</a>].</p><p><b><i>HNF1B-</i>MODY (MODY5, or renal cysts and diabetes [RCAD] syndrome)</b> is a multisystem disorder in which renal involvement is more common than diabetes. Renal manifestations can include structural defects evident at birth and later-onset functional defects.</p><p>Of the renal structural defects, the most common are renal cysts, which can be evident prenatally as <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> bilateral hyperechogenic kidneys [<a class="bk_pop" href="#mody-ov.REF.decramer.2007.923">Decramer et al 2007</a>]); postnatally the majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have normal-size or small kidneys with hyperechogenicity and/or renal cysts [<a class="bk_pop" href="#mody-ov.REF.heidet.2010.1079">Heidet et al 2010</a>]. Other structural abnormalities can include absence of a kidney and renal hypoplasia.</p><p>Renal functional defects include renal magnesium wasting, which can lead to life-threatening hypomagnesemia, and hyperuricemia, which can manifest as early-onset gout.</p><p>Early-onset diabetes mellitus is the most common extrarenal manifestation and usually presents after the identification of childhood-onset renal disease. The mean age of onset of diabetes is 24 years [<a class="bk_pop" href="#mody-ov.REF.chen.2010.3326">Chen et al 2010</a>], but ranges from the neonatal period [<a class="bk_pop" href="#mody-ov.REF.edghill.2006b.1301">Edghill et al 2006b</a>] to late middle age [<a class="bk_pop" href="#mody-ov.REF.edghill.2006a.84">Edghill et al 2006a</a>].</p><p>Additional findings can include pancreatic atrophy, genital tract abnormalities in females, abnormal liver function, and primary hyperparathyroidism [<a class="bk_pop" href="#mody-ov.REF.montoli.2002.397">Montoli et al 2002</a>, <a class="bk_pop" href="#mody-ov.REF.bellann_chantelot.2004.510">Bellann&#x000e9;-Chantelot et al 2004</a>, <a class="bk_pop" href="#mody-ov.REF.ferr_.2013.4089">Ferr&#x000e8; et al 2013</a>].</p><p><i>HNF1B</i> pathogenic variants include single-nucleotide variants as well as intragenic deletions. In addition, a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> contiguous <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> comprising at least 1.2 Mb at <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 17q12 that includes all of <i>HNF1B</i> and at least seven (and as many as 14) contiguous genes accounts for approximately 50% of genetic alterations in adults with <i>HNF1B</i>-MODY [<a class="bk_pop" href="#mody-ov.REF.bellann_chantelot.2005.3126">Bellann&#x000e9;-Chantelot et al 2005</a>, <a class="bk_pop" href="#mody-ov.REF.edghill.2008b.627">Edghill et al 2008b</a>]. Those with the <a href="/books/n/gene/mdel17q12/">17q12 recurrent deletion syndrome</a> may have neurologic features including autism spectrum disorder (ASD) and cognitive impairment [<a class="bk_pop" href="#mody-ov.REF.raile.2009.2658">Raile et al 2009</a>, <a class="bk_pop" href="#mody-ov.REF.clissold.2015.102">Clissold et al 2015</a>] that are not caused by <i>HNF1B</i> <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> [<a class="bk_pop" href="#mody-ov.REF.clissold.2016.203">Clissold et al 2016</a>].</p><p><b><i>HNF4A</i>-MODY (MODY1).</b> A dual <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is observed in <i>HNF4A</i>-MODY: some individuals have transient hyperinsulinemic hypoglycemia in the neonatal period, followed later by diabetes in late adolescence or adulthood. The nature and timing of the transition remain poorly defined [<a class="bk_pop" href="#mody-ov.REF.bacon.2016a.965">Bacon et al 2016a</a>].</p></div><div id="mody-ov._escape__3_Evaluation_Strategy_t"><h2 id="_mody-ov__escape__3_Evaluation_Strategy_t_">3. Evaluation Strategy to Identify the Genetic Cause of MODY in a Proband</h2><p>Establishing a specific genetic cause of MODY in an individual whose clinical findings suggest MODY (see <a href="#mody-ov._escape__1_Clinical_Characterist">Clinical Characteristics</a>) can aid in management of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> of family members, and medical surveillance of at-risk family members [<a class="bk_pop" href="#mody-ov.REF.rubiocabezas.2014.47">Rubio-Cabezas et al 2014</a>].</p><p>Establishing the specific genetic cause of MODY usually involves a medical history, family history, physical examination, diabetes-related laboratory testing, and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p><b>Medical history.</b> In MODY, diabetes onset is most often in adolescence or young adulthood (age &#x0003c;35 years). Other relevant medical history, such as birth history or complications and other medical problems, varies by genetic cause (<a class="figpopup" href="/books/NBK500456/table/mody-ov.T.maturityonset_diabetes_of_the/?report=objectonly" target="object" rid-figpopup="figmodyovTmaturityonsetdiabetesofthe" rid-ob="figobmodyovTmaturityonsetdiabetesofthe">Table 1</a>). A history of developmental renal disease, particularly cystic renal disease, should prompt suspicion of <i>HNF1B</i>-MODY.</p><p><b>Family history.</b> A three-generation family history should be obtained, with attention to relatives with diabetes mellitus and documentation of relevant findings (e.g., age at onset of diabetes, body habitus at onset, insulin independence) either through direct examination or review of medical records, including results of any <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. As <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>HNF1B</i> can cause renal disease in isolation and diabetes in isolation, a family history of multiple individuals with renal disease and others with diabetes should also raise consideration of <i>HNF1B</i>-MODY.</p><p><b>Physical examination.</b> Although MODY is typically characterized by and compatible with normal weight or mildly overweight status, obesity does occur in some of the uncommon genetic causes of MODY. Furthermore, obesity can coexist with any type of MODY. In one study at least 4.5% of obese and overweight adolescents enrolled in a clinical trial to treat type 2 diabetes had MODY (mostly <i>HNF4A</i>-MODY, <i>GCK</i>-MODY, or <i>HNF1A</i>-MODY) [<a class="bk_pop" href="#mody-ov.REF.kleinberger.2018.583">Kleinberger et al 2018</a>]. Since MODY does not protect one from being overweight, MODY may occur together with insulin resistance.</p><p>Other than findings consistent with gout (suggestive of <i>HNF1B</i>-MODY), no findings on physical examination can distinguish one cause of MODY from others.</p><p><b>Laboratory testing</b></p><ul><li class="half_rhythm"><div>In <i>GCK</i>-MODY, the levels of serum glucose and hemoglobin A1c (HbA1c) can help with diagnosis because they will fall within the following expected ranges:</div><ul><li class="half_rhythm"><div><b>Fasting serum glucose.</b> Typical range 99-144 mg/dL (5.49-7.99 mmol/L) [<a class="bk_pop" href="#mody-ov.REF.ellard.2008.546">Ellard et al 2008</a>]</div></li><li class="half_rhythm"><div><b>HbA1c.</b> Typical range 5.6%-7.3% (38-56 mmol/mol) at age &#x02264;40 years and 5.9%-7.6% (41-60 mmol/mol) at age &#x0003e;40 years [<a class="bk_pop" href="#mody-ov.REF.steele.2013.e65326">Steele et al 2013</a>]</div></li></ul></li><li class="half_rhythm"><div>High-sensitivity C-reactive protein (hsCRP) is useful as values are lower in <i>HNF1A</i>-MODY (i.e., &#x0003c;0.75 mg/L) than in other forms of diabetes [<a class="bk_pop" href="#mody-ov.REF.mcdonald.2011b.1860">McDonald et al 2011b</a>, <a class="bk_pop" href="#mody-ov.REF.thanabalasingham.2011.2801">Thanabalasingham et al 2011</a>].</div></li></ul><p><b>Molecular genetic testing</b> approaches to determine the associated MODY <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> can include a combination of <b>gene-targeted testing</b> (serial singe-gene or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> analysis or <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>), depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing requires that the clinician determine which gene(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because of the clinical and genetic heterogeneity of MODY, the genetic cause of MODY in a person with the distinctive clinical findings described in <a class="figpopup" href="/books/NBK500456/table/mody-ov.T.maturityonset_diabetes_of_the/?report=objectonly" target="object" rid-figpopup="figmodyovTmaturityonsetdiabetesofthe" rid-ob="figobmodyovTmaturityonsetdiabetesofthe">Table 1</a> could be established by single-gene (or serial single-gene) testing (see <a href="#mody-ov.Option_1">Option 1</a>), whereas those with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> indistinguishable from other genetic causes of MODY are more likely to be diagnosed using a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> (see <a href="#mody-ov.Option_2">Option 2</a>). If the genetic cause is not identified using clinically available testing or if the individual has additional clinical features, comprehensive genomic testing (see <a href="#mody-ov.Option_3">Option 3</a>) may be considered.</p><div id="mody-ov.Option_1"><h3>Option 1</h3><p>When the phenotypic and laboratory findings are consistent with one or more genetic causes of MODY (<a class="figpopup" href="/books/NBK500456/table/mody-ov.T.maturityonset_diabetes_of_the/?report=objectonly" target="object" rid-figpopup="figmodyovTmaturityonsetdiabetesofthe" rid-ob="figobmodyovTmaturityonsetdiabetesofthe">Table 1</a>), <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches to define the genetic cause can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and/or <b>CMA</b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of the most likely genes is performed first. If no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>-sized deletions could be considered, especially for those genes (<i>CEL</i>, <i>GCK</i>, <i>HNF1A</i>, <i>HNF1B</i>, and <i>HNF4A)</i> in which whole-gene or multiexon deletions have been identified.</p></div><div id="mody-ov.Option_2"><h3>Option 2</h3><p><b>A MODY <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes the 14 known MODY-related genes and other genes of interest is most likely to identify the genetic cause of MODY at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#mody-ov.REF.ellard.2013.1958">Ellard et al 2013</a>, <a class="bk_pop" href="#mody-ov.REF.alkortaaranburu.2016.523">Alkorta-Aranburu et al 2016</a>]. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some custom laboratory-designed multigene panels may include genes not associated with MODY but possibly associated with other types of monogenic diabetes; other custom laboratory-designed panels may not include the genes that rarely cause MODY. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that include genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. Note: Given that whole-gene and/or multiexon deletions have been identified in <i>GCK</i>, <i>HNF1A</i>, <i>HNF1B</i>, and <i>HNF4A</i> (<a class="figpopup" href="/books/NBK500456/table/mody-ov.T.maturityonset_diabetes_of_the/?report=objectonly" target="object" rid-figpopup="figmodyovTmaturityonsetdiabetesofthe" rid-ob="figobmodyovTmaturityonsetdiabetesofthe">Table 1</a>), a multigene panel that also includes deletion/duplication analysis is recommended.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Chromosomal microarray analysis (CMA</b>) using oligonucleotide <a class="def" href="/books/n/gene/glossary/def-item/comparative-genomic-hybridization/">comparative genomic hybridization</a> (CGH) or single-nucleotide <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> (SNP) arrays may be considered in the following cases:</p><ul><li class="half_rhythm"><div>In individuals with distinguishing phenotypic features suggestive of a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a>, such as the <a href="/books/n/gene/mdel17q12/">17q12 recurrent deletion syndrome</a>, which is associated with a 1.2-Mb (megabase) or larger deletion that includes <i>HNF1B</i></div></li><li class="half_rhythm"><div>To estimate the breakpoints and size of a whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> detected by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a></div></li></ul></div><div id="mody-ov.Option_3"><h3>Option 3</h3><p><b>Exome sequencing</b> does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is likely causative. Furthermore, it may be possible to reanalyze existing <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> data for MODY-related genes not included in the <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> used to test a given patient.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p></div></div><div id="mody-ov._escape__4_Management_of_MODY_Ba"><h2 id="_mody-ov__escape__4_Management_of_MODY_Ba_">4. Management of MODY Based on Genetic Cause</h2><div id="mody-ov.T.mody_management_by_genetic_cau" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>MODY: Management by Genetic Cause</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK500456/table/mody-ov.T.mody_management_by_genetic_cau/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mody-ov.T.mody_management_by_genetic_cau_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" style="text-align:left;vertical-align:middle;">Pathophysiology</th><th id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3" colspan="4" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Treatment</th><th id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" style="text-align:left;vertical-align:middle;">References</th></tr><tr><th headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3" id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">None</th><th headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3" id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Diet</th><th headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3" id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OAD</th><th headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3" id="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Insulin</th></tr></thead><tbody><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCC8</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ATP-sensitive potassium channel dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sulfonylureas</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.bowman.2012.123">Bowman et al [2012]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APPL1</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Insulin secretion defect</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.prudente.2015.177">Prudente et al [2015]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>BLK</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Insulin secretion defect</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.borowiec.2009.14460">Borowiec et al [2009]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CEL</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pancreatic endocrine &#x00026; exocrine dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.raeder.2006.54">Raeder et al [2006]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GCK</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction (glucose-sensing defect)</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Except possibly in pregnancy&#x000a0;<sup>1</sup></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.stride.2014.54">Stride et al [2014]</a>, <a class="bk_pop" href="#mody-ov.REF.chakera.2015.1383">Chakera et al [2015]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HNF1A</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction; mainly insulin secretory defect</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Low-dose sulfonylureas or meglitinides; GLP-1 agonists also used</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be required&#x000a0;<sup>2</sup></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.shepherd.2003.3191">Shepherd et al [2003]</a>, <a class="bk_pop" href="#mody-ov.REF.tuomi.2006.189">Tuomi et al [2006]</a>, <a class="bk_pop" href="#mody-ov.REF._stoft.2014.1797">&#x000d8;stoft et al [2014]</a>, <a class="bk_pop" href="#mody-ov.REF.bacon.2016b.976">Bacon et al [2016b]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HNF1B</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">A minority respond to sulfonylureas.</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Commonly needed</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.duboislaforgue.2017.1436">Dubois-Laforgue et al [2017]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HNF4A</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction (mainly insulin secretory defect)</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sensitive to sulfonylureas</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.pearson.2005.878">Pearson et al [2005]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>INS</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X&#x000a0;<sup>3</sup></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.molven.2008.1131">Molven et al [2008]</a>, <a class="bk_pop" href="#mody-ov.REF.boesgaard.2010.42">Boesgaard et al [2010]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNJ11</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ATP-sensitive potassium channel dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sulfonylureas</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.bonnefond.2012.e37423">Bonnefond et al [2012]</a>, <a class="bk_pop" href="#mody-ov.REF.liu.2013.2609">Liu et al [2013]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KLF11</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Decreased glucose sensitivity of &#x003b2;-cells</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.neve.2005.4807">Neve et al [2005]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NEUROD1</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.malecki.1999.323">Malecki et al [1999]</a>, <a class="bk_pop" href="#mody-ov.REF.kristinsson.2001.2098">Kristinsson et al [2001]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PAX4</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.mauvaisjarvis.2004.3151">Mauvais-Jarvis et al [2004]</a>, <a class="bk_pop" href="#mody-ov.REF.plengvidhya.2007.2821">Plengvidhya et al [2007]</a></td></tr><tr><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PDX1</i></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x003b2;-cell dysfunction</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_3 hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X</td><td headers="hd_h_mody-ov.T.mody_management_by_genetic_cau_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#mody-ov.REF.clocquet.2000.1856">Clocquet et al [2000]</a>, <a class="bk_pop" href="#mody-ov.REF.fajans.2010.7">Fajans et al [2010]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">GLP-1 = glucagon-like peptide-1; OAD = oral antidiabetic agents</p></div></dd><dt>1. </dt><dd><div id="mody-ov.TF.2.1"><p class="no_margin">Depending on <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> of the fetus (see <a class="figpopup" href="/books/NBK500456/table/mody-ov.T.influence_of_parental_and_feta/?report=objectonly" target="object" rid-figpopup="figmodyovTinfluenceofparentalandfeta" rid-ob="figobmodyovTinfluenceofparentalandfeta">Table 3</a>) [<a class="bk_pop" href="#mody-ov.REF.spyer.2001.240">Spyer et al 2001</a>]</p></div></dd><dt>2. </dt><dd><div id="mody-ov.TF.2.2"><p class="no_margin">Patients with <i>HNF1A</i>-MODY and diabetes of several years' duration may continue to require insulin.</p></div></dd><dt>3. </dt><dd><div id="mody-ov.TF.2.3"><p class="no_margin">May require only small doses of insulin</p></div></dd></dl></div></div></div><p><b><i>GCK-</i>MODY</b> is associated with mild, stably increased fasting blood sugars and HbA1c ranging from 5.6% to 7.6% [<a class="bk_pop" href="#mody-ov.REF.steele.2013.e65326">Steele et al 2013</a>]. Insulin secretion and regulation are fully intact. Comparison of cohorts with <i>GCK</i>-MODY on treatment versus on no treatment does not show significant differences in HbA1c. Moreover, studies have shown that discontinuing pharmacologic therapy does not alter HbA1c [<a class="bk_pop" href="#mody-ov.REF.stride.2014.54">Stride et al 2014</a>]. For this reason, <i>GCK</i>-MODY in isolation (i.e., without co-occurrence of type 1 or type 2 diabetes or pregnancy) does not require pharmacologic therapy [<a class="bk_pop" href="#mody-ov.REF.chakera.2015.1383">Chakera et al 2015</a>].</p><p>At the level of glycemic control observed in <i>GCK-</i>MODY, long-term complications are rare. In a cross-sectional study of long-term complications in adults with <i>GCK</i>-MODY (mean age 48.6 years), only the prevalence of non-proliferative (also known as background) retinopathy was increased compared to healthy controls [<a class="bk_pop" href="#mody-ov.REF.steele.2014.279">Steele et al 2014</a>]. Thus, it would be reasonable to screen annually for retinopathy in older individuals with <i>GCK</i>-MODY; however, annual screening for other microvascular and macrovascular complications typically associated with diabetes appears to be low-yield.</p><p><b>The co-occurrence of type 1 or type 2 diabetes</b>. Treatment is dictated by the type of co-occurring diabetes. Clinicians should continue to account for the increased set point for glucose-stimulated insulin secretion as well as lower threshold for counter-regulation seen in <i>GCK</i>-MODY by setting the HbA1c treatment goal within the expected range for <i>GCK</i>-MODY [<a class="bk_pop" href="#mody-ov.REF.uday.2014.327">Uday et al 2014</a>].</p><p><b>Pregnancy in a woman with <i>GCK</i>-MODY.</b> Insulin may be required; recommendations for treatment are based on the known or inferred fetal <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> [<a class="bk_pop" href="#mody-ov.REF.spyer.2001.240">Spyer et al 2001</a>, <a class="bk_pop" href="#mody-ov.REF.chakera.2015.1383">Chakera et al 2015</a>] (<a class="figpopup" href="/books/NBK500456/table/mody-ov.T.influence_of_parental_and_feta/?report=objectonly" target="object" rid-figpopup="figmodyovTinfluenceofparentalandfeta" rid-ob="figobmodyovTinfluenceofparentalandfeta">Table 3</a>).</p><p>Fetal <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>:</p><ul><li class="half_rhythm"><div><b>Known.</b> Genotyping the fetus solely for prenatal management is not recommended due to the risks associated with invasive prenatal testing; however, when such testing is performed for other indications, determining if the fetus has inherited the maternal <i>GCK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is helpful.</div></li><li class="half_rhythm"><div><b>Inferred</b>. Using abdominal circumference measurements obtained on second trimester ultrasound examination, it is assumed that a fetal abdominal circumference &#x0003e;75<sup>th</sup> centile indicates that the fetus has not inherited the maternal <i>GCK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#mody-ov.REF.chakera.2015.1383">Chakera et al 2015</a>].</div></li></ul><p>Fetal outcome:</p><ul><li class="half_rhythm"><div>If the fetus has inherited the maternal <i>GCK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the fetus will produce normal amounts of insulin and grow normally. Current recommendations do not support use of insulin in the mother.</div></li><li class="half_rhythm"><div>If the fetus has not inherited the maternal <i>GCK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the fetus will respond to maternal hyperglycemia with excess insulin production resulting in excess growth. While current recommendations are to treat the mother with insulin to decrease the risk of macrosomia, data to support these recommendations are limited.</div></li><li class="half_rhythm"><div>Note: While more data currently support fetal <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-based treatment, some advocate treating all women with <i>GCK</i>-MODY with insulin early in pregnancy [<a class="bk_pop" href="#mody-ov.REF.bacon.2015.236.e1">Bacon et al 2015</a>]. Additional studies on pregnancy management and outcomes are warranted.</div></li></ul><p>Additional considerations:</p><ul><li class="half_rhythm"><div>Glycemic excursions are difficult to manage with insulin in <i>GCK</i>-MODY as exogenous insulin will suppress endogenous insulin secretion and counter-regulation occurs at a lower blood glucose value [<a class="bk_pop" href="#mody-ov.REF.guenat.2000.377">Guenat et al 2000</a>]. High doses of insulin may be required [<a class="bk_pop" href="#mody-ov.REF.bacon.2015.236.e1">Bacon et al 2015</a>, <a class="bk_pop" href="#mody-ov.REF.chakera.2015.1383">Chakera et al 2015</a>, <a class="bk_pop" href="#mody-ov.REF.hattersley.2017.769">Hattersley &#x00026; Patel 2017</a>].</div></li><li class="half_rhythm"><div>If the fetus inherits a <i>GCK</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from the father or has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>GCK</i> pathogenic variant, the fetus will have decreased insulin secretion leading to lower birth weight.</div></li></ul><div id="mody-ov.T.influence_of_parental_and_feta" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Influence of Parental and Fetal Genotype on Fetal Growth and Recommended Management of the Mother during a Pregnancy at Risk for <i>GCK</i>-MODY</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK500456/table/mody-ov.T.influence_of_parental_and_feta/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mody-ov.T.influence_of_parental_and_feta_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_1" rowspan="3" scope="col" colspan="1" headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_1" style="text-align:left;vertical-align:middle;">Source of <i>GCK</i> Pathogenic Variant</th><th id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2" colspan="4" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Fetal Growth and Recommended Management during Pregnancy: <i>GCK</i> Variant Present in Fetus?&#x000a0;<sup>1</sup></th></tr><tr><th headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2" id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Yes</th><th headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2" id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">No</th></tr><tr><th headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1" id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Fetal growth</th><th headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1" id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2" id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fetal growth&#x000a0;<sup>2</sup></th><th headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2" id="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment&#x000a0;<sup>3</sup></th></tr></thead><tbody><tr><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mother</b></td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Birth weight &#x0003e;700 g compared to normal (i.e., fetus with maternal <i>GCK</i> variant)</td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Insulin is recommended (dose required to lower mother's fasting glucose is &#x0003e; replacement dose).</div></li><li class="half_rhythm"><div>Consider delivery at 38 wks' gestation when abdominal circumference &#x0003e;75<sup>th</sup> centile.</div></li></ul></td></tr><tr><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Father (or</b><br /><b><a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>)</b></td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Restricted: birth weight 400 g &#x0003c; normal</td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_1 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_1_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_2_2 hd_h_mody-ov.T.influence_of_parental_and_feta_1_1_3_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mody-ov.TF.3.1"><p class="no_margin">When the fetal <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> is not known, it can be inferred from abdominal circumference on second trimester fetal ultrasound.</p></div></dd><dt>2. </dt><dd><div id="mody-ov.TF.3.2"><p class="no_margin">Assessed by second-trimester ulstrasound [<a class="bk_pop" href="#mody-ov.REF.spyer.2001.240">Spyer et al [2001]</a></p></div></dd><dt>3. </dt><dd><div id="mody-ov.TF.3.3"><p class="no_margin"><a class="bk_pop" href="#mody-ov.REF.chakera.2015.1383">Chakera et al [2015]</a>, <a class="bk_pop" href="#mody-ov.REF.colom.2010.605">Colom &#x00026; Corcoy [2010]</a></p></div></dd></dl></div></div></div><p><b><i>HNF1A-</i>MODY.</b> The first-line therapy is low dose sulfonylureas which act downstream of the genetic defect and increase insulin secretion via a glucose-independent mechanism [<a class="bk_pop" href="#mody-ov.REF.bacon.2016b.976">Bacon et al 2016b</a>].</p><p>Patients with <i>HNF1A-</i>MODY previously misdiagnosed with type 1 diabetes and treated with insulin may be able to discontinue insulin therapy and start treatment with sulfonylureas without the risk of ketoacidosis [<a class="bk_pop" href="#mody-ov.REF.shepherd.2003.3191">Shepherd et al 2003</a>]. Transition from insulin to sulfonylureas is often associated with a decrease in HbA1c which is associated with decreased diabetes-related complications [<a class="bk_pop" href="#mody-ov.REF.bacon.2016b.976">Bacon et al 2016b</a>]. These observations plus the low cost of sulfonylureas make them particularly appropriate for treatment of <i>HNF1A</i>-MODY.</p><p>In the US, glyburide is the most commonly used sulfonylurea for <i>HNF1A</i>-MODY. Starting doses should be low and insulin doses may need to be lowered or discontinued to avoid hypoglycemia.</p><p>Because individuals with <i>HNF1A</i>-MODY have normal or even increased insulin sensitivity, sulfonylureas can (even at low doses) cause hypoglycemia, which may limit their use in some patients. In such cases, treatment with meglitinides (which act on the same receptor as sulfonylureas, but with decreased binding affinity and decreased duration of action) can be considered. Studies showed that in <i>HNF1A</i>-MODY nateglinide caused lower postprandial glucose levels and reduced the risk of hypoglycemia compared to the sulfonylurea glibenclamide [<a class="bk_pop" href="#mody-ov.REF.tuomi.2006.189">Tuomi et al 2006</a>]. GLP-1 agonists have also been effective in treating <i>HNF1A</i>-MODY. The glucose-lowering effect of liraglutide and risk of hypoglycemia are less than those of the sulfonylurea glimepiride [<a class="bk_pop" href="#mody-ov.REF._stoft.2014.1797">&#x000d8;stoft et al 2014</a>].</p><p>Over time the glycemic control of sulfonylureas may deteriorate in individuals with <i>HNF1A</i>-MODY, especially those who are obese [<a class="bk_pop" href="#mody-ov.REF.bacon.2016b.976">Bacon et al 2016b</a>]. The best augmentative therapy is unclear; GLP-1 agonists and insulin therapy are appropriate options.</p><p>Because of the increased risk of cardiovascular disease (despite the accompanying elevated levels of HDL and low levels of high-sensitivity C- reactive protein (hsCRP), persons with <i>HNF1A-</i>MODY should be treated with statin therapy by age 40 years [<a class="bk_pop" href="#mody-ov.REF.steele.2010.157">Steele et al 2010</a>].</p><p>Hyperglycemia during pregnancy in a woman with <i>HNF1A</i>-MODY can be managed with sulfonylureas or insulin and result in normal-size infants. However, there are concerns regarding placental transfer of sulfonylureas. Of note, a meta-analysis showed increased risk of macrosomia and neonatal hypoglycemia in pregnancies treated with glyburide compared to insulin [<a class="bk_pop" href="#mody-ov.REF.poolsup.2014.e109985">Poolsup et al 2014</a>].</p><p>Of note, the <a class="def" href="/books/n/gene/glossary/def-item/background-risk/">background risk</a> for birth defects in the general population is approximately 3%-4%. Women who have pre-pregnancy insulin-dependent diabetes are at increased risk of having a child with a birth defect (~6%-8% risk). Women with non-insulin dependent diabetes prior to pregnancy are also at risk greater than the general population of having a baby with a birth defect; however, their risk is less than that of women who have insulin-dependent diabetes prior to pregnancy.</p><p>Appropriate glycemic control during pregnancy may reduce (though does not eliminate) the risk of having a child with a birth defect and also decrease the risk of having a child with neonatal diabetes-related complications (e.g., macrosomia, hypoglycemia, and electrolyte abnormalities). In a meta-analysis by <a class="bk_pop" href="#mody-ov.REF.silva.2012.225">Silva et al [2012]</a> the rate of birth defects was not significantly different between women who took an oral hypoglycemic (including glyburide) and women who required insulin to treat diabetes during pregnancy. Given the risks to the fetus associated with diabetes during pregnancy, aggressive treatment of chronic maternal hyperglycemia is recommended.</p><p>To screen for fetal birth defects in pregnant women with diabetes, prenatal high-resolution ultrasound with fetal echocardiogram is recommended; referral to a maternal-fetal medicine specialist may also be considered.</p><p>See <a href="http://www.mothertobaby.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mothertobaby.org</a> for more information on the use of medications during pregnancy [<a class="bk_pop" href="#mody-ov.REF.silva.2012.225">Silva et al 2012</a>].</p><p><b><i>HNF1B-</i>MODY.</b> Despite significant homology between the transcription factors HNF1A and HNF1B, <i>HNF1B</i>-MODY does not show the same sensitivity to sulfonylureas as <i>HNF1A</i>-MODY. Insulin sensitivity to endogenous glucose is decreased even though peripheral insulin sensitivity is normal [<a class="bk_pop" href="#mody-ov.REF.brackenridge.2006.405">Brackenridge et al 2006</a>]. While some individuals with <i>HNF1B</i>-MODY respond to oral medications, including sulfonylureas, insulin therapy is often required [<a class="bk_pop" href="#mody-ov.REF.brackenridge.2006.405">Brackenridge et al 2006</a>, <a class="bk_pop" href="#mody-ov.REF.duboislaforgue.2017.1436">Dubois-Laforgue et al 2017</a>].</p><p><b><i>HNF4A-</i>MODY.</b> As with <i>HNF1A</i>-MODY, sulfonylureas are the established first-line treatment for <i>HNF4A</i>-MODY [<a class="bk_pop" href="#mody-ov.REF.pearson.2005.878">Pearson et al 2005</a>]. It is reasonable to assume that individuals with <i>HNF4A</i>-MODY (like those with <i>HNF1A</i>-MODY) may respond to meglitinides and GLP-1 agonists; however, no formal data support this assumption.</p><p><b>Other.</b> Data on treatment outcomes of MODY of rare causes are unavailable and, thus, treatment relies on clinical judgment. Reported treatment of individuals is found in <a class="figpopup" href="/books/NBK500456/table/mody-ov.T.mody_management_by_genetic_cau/?report=objectonly" target="object" rid-figpopup="figmodyovTmodymanagementbygeneticcau" rid-ob="figobmodyovTmodymanagementbygeneticcau">Table 2</a>.</p></div><div id="mody-ov._escape__5_Risk_Assessment_and_S"><h2 id="_mody-ov__escape__5_Risk_Assessment_and_S_">5. Risk Assessment and Surveillance of At-Risk Relatives for Early Detection and Treatment of MODY</h2><p>The advantages of early clarification of the genetic status of asymptomatic family members at risk for MODY:</p><ul><li class="half_rhythm"><div>Routine surveillance to identify hyperglycemia enables prompt and appropriate treatment based on the type of MODY (<a class="figpopup" href="/books/NBK500456/table/mody-ov.T.mody_management_by_genetic_cau/?report=objectonly" target="object" rid-figpopup="figmodyovTmodymanagementbygeneticcau" rid-ob="figobmodyovTmodymanagementbygeneticcau">Table 2</a>).</div></li><li class="half_rhythm"><div>For those at increased risk, early intervention reduces the long-term risk of hyperglycemia-related microvascular and macrovascular complications [<a class="bk_pop" href="#mody-ov.REF.bacon.2016a.965">Bacon et al 2016a</a>, <a class="bk_pop" href="#mody-ov.REF.bacon.2016b.976">Bacon et al 2016b</a>].</div></li><li class="half_rhythm"><div>Families with individuals with MODY as well as the much more common type 1 and type 2 diabetes [<a class="bk_pop" href="#mody-ov.REF.uday.2014.327">Uday et al 2014</a>] can be assured that each individual will receive the appropriate surveillance and therapy for his/her diagnosis.</div></li></ul><p>Studies have shown that family members at risk for MODY are generally in favor of early predictive genetic testing [<a class="bk_pop" href="#mody-ov.REF.liljestr_m.2007.1571">Liljestr&#x000f6;m et al 2007</a>, <a class="bk_pop" href="#mody-ov.REF.bosma.2015.1385">Bosma et al 2015</a>].</p><div id="mody-ov.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Maturity-onset diabetes of the young (MODY) is generally inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. <i>De novo</i> pathogenic variants do occur.</p><p>Note: Biallelic pathogenic variants in <i>PDX1</i> are associated with pancreatic agenesis, and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>GCK</i> are associated with permanent neonatal diabetes. Autosomal recessive inheritance of <i>PDX1</i>-related pancreatic agenesis and <i>GCK-</i>related permanent neonatal diabetes are not addressed in this <i>GeneReview</i>; see <a href="/books/n/gene/dmn/">Permanent Neonatal Diabetes</a> for more information on these phenotypes and recurrence risks.</p></div><div id="mody-ov.Risk_to_Family_Members"><h3>Risk to Family Members</h3><div id="mody-ov.T.risk_assessment_of_family_memb" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Risk Assessment of Family Members of a Proband with Maturity-Onset Diabetes of the Young (MODY)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK500456/table/mody-ov.T.risk_assessment_of_family_memb/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mody-ov.T.risk_assessment_of_family_memb_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_1" style="text-align:left;vertical-align:middle;">Family Members</th><th id="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_2" style="text-align:left;vertical-align:middle;">Clinical &#x00026; Genetic Status Possibilities</th><th id="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Evaluation of Apparently Asymptomatic Family Member: MODY-Related Pathogenic Variant Identified in Proband?</th></tr><tr><th headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_3" id="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Yes</th><th headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_3" id="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:center;vertical-align:middle;">No</th></tr></thead><tbody><tr><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Parents of <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></td><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Affected &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for MODY-related pathogenic or <a class="def" href="/books/n/gene/glossary/def-item/likely-pathogenic/">likely pathogenic variant</a> OR</div></li><li class="half_rhythm"><div>Apparently asymptomatic &#x00026; <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> due to reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> or <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a> OR</div></li><li class="half_rhythm"><div>Not <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> because either:</div><ul><li class="half_rhythm"><div>Pathogenic or <a class="def" href="/books/n/gene/glossary/def-item/likely-pathogenic/">likely pathogenic variant</a> was <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> in <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>&#x000a0;<sup>1,&#x000a0;2</sup></div></li><li class="half_rhythm"><div>Parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a></div></li></ul></li></ul></td><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_3 hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_2_1" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Molecular genetic testing
<ul><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pathogenic or <a class="def" href="/books/n/gene/glossary/def-item/likely-pathogenic/">likely pathogenic variant</a> is identified, surveillance for early manifestations of MODY (see <a href="#mody-ov._escape__4_Management_of_MODY_Ba">Management</a>)</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> pathogenic or <a class="def" href="/books/n/gene/glossary/def-item/likely-pathogenic/">likely pathogenic variant</a> is not identified, monitoring consistent w/standard of care for general population</div></li></ul></td><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_3 hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_2_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Surveillance for early manifestations of MODY (see <a href="#mody-ov._escape__4_Management_of_MODY_Ba">Management</a>)</td></tr><tr><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Sibs of <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></td><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>If one parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>/<a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>: 50% risk to sibs of inheriting variant / being at risk for MODY</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known MODY-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that is not detectable in leukocyte DNA of either parent: ~1% <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs due to the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>&#x000a0;<sup>3</sup></div></li></ul></td></tr><tr><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Offspring of <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></td><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">50% chance of inheriting the MODY-related pathogenic or <a class="def" href="/books/n/gene/glossary/def-item/likely-pathogenic/">likely pathogenic variant</a></td></tr><tr><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other family members</b></td><td headers="hd_h_mody-ov.T.risk_assessment_of_family_memb_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If a parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a MODY-related <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his/her family members may be at risk.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mody-ov.TF.4.1"><p class="no_margin">The proportion of cases caused by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is unknown for the majority of MODY-related genes. In <a href="/books/n/gene/mdel17q12/">17q12 recurrent deletion syndrome</a> (associated with MODY5), 70% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a <i>de novo</i> genetic alteration. A limited number of case reports describe de <i>novo</i> variants in <i>GCK, HNF1A</i>, and <i>HNF4A</i>; based on one small study, the <i>de novo</i> rate for these genes may approach 7% [<a class="bk_pop" href="#mody-ov.REF.stanik.2014.480">Stanik et al 2014</a>].</p></div></dd><dt>2. </dt><dd><div id="mody-ov.TF.4.2"><p class="no_margin">When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p></div></dd><dt>3. </dt><dd><div id="mody-ov.TF.4.3"><p class="no_margin"><a class="bk_pop" href="#mody-ov.REF.rahbari.2016.126">Rahbari et al [2016]</a></p></div></dd></dl></div></div></div></div></div><div id="mody-ov.Resources"><h2 id="_mody-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Diabetes Association (ADA)</b></div><div><b>Phone:</b> 1-800-DIABETES (800-342-2383)</div><div><b>Email:</b> AskADA@diabetes.org</div><div><a href="http://www.diabetes.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org</a></div></li><li class="half_rhythm"><div><b>Diabetes Genes</b></div><div><i>Diabetesgenes.org aims to provide information for patients and professionals on research and clinical care in genetic types of diabetes.</i></div><div>United Kingdom</div><div><a href="http://www.diabetesgenes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetesgenes.org</a></div></li><li class="half_rhythm"><div><b>Diabetes UK</b></div><div>United Kingdom</div><div><b>Phone:</b> 0345 123 2399</div><div><b>Fax:</b> 020 7424 1001</div><div><b>Email:</b> info@diabetes.org.uk</div><div><a href="http://www.diabetes.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.diabetes.org.uk</a></div></li><li class="half_rhythm"><div><b>International Society for Pediatric and Adolescent Diabetes (ISPAD)</b></div><div>Germany</div><div><b>Phone:</b> +49 (0)30 24603-210</div><div><b>Fax:</b> +49 (0)30 24603-200</div><div><b>Email:</b> secretariat@ispad.org</div><div><a href="http://www.ispad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.ispad.org</a></div></li></ul></div><div id="mody-ov.References"><h2 id="_mody-ov_References_">References</h2><div id="mody-ov.Published_Guidelines__Policy_Sta"><h3>Published Guidelines / Policy Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.abmg_board_of_directors.2015.68">ABMG Board of Directors.  ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. <span><span class="ref-journal">Genet Med. </span>2015;<span class="ref-vol">17</span>:68–9.</span> [<a href="/pubmed/25356965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25356965</span></a>]</div></li></ul></div><div id="mody-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.alkortaaranburu.2016.523">Alkorta-Aranburu G, Sukhanova M, Carmody D, Hoffman T, Wysinger L, Keller-Ramey J, Li Z, Johnson AK, Kobiernicki F, Botes S, Fitzpatrick C, Das S, Del Gaudio D. Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach. <span><span class="ref-journal">J Pediatr Endocrinol Metab. </span>2016;2016;<span class="ref-vol">29</span>:523–31.</span> [<a href="/pubmed/26894574" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26894574</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bacon.2016a.965">Bacon S, Kyithar MP, Condron EM, Vizzard N, Burke M, Byrne MM. Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood. <span><span class="ref-journal">Acta Diabetol. </span>2016a;<span class="ref-vol">53</span>:965–72.</span> [<a href="/pubmed/27552834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27552834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bacon.2016b.976">Bacon S, Kyithar MP, Rizvi SR, Donnelly E, Mccarthy A, Burke M, Colclough K, Ellard S, Byrne MM. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort. <span><span class="ref-journal">Diabet Med. </span>2016b;<span class="ref-vol">33</span>:976–84.</span> [<a href="/pubmed/26479152" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26479152</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bacon.2015.236.e1">Bacon S, Schmid J, McCarthy A, Edwards J, Fleming A, Kinsley B, Firth R, Byrne B, Gavin C, Byrne MM. The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young. <span><span class="ref-journal">Am J Obstet Gynecol. </span>2015;<span class="ref-vol">213</span>:236.e1–7.</span> [<a href="/pubmed/25935773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25935773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bellann_chantelot.2004.510">Bellann&#x000e9;-Chantelot C, Chauveau D, Gautier JF, Dubois-Laforgue D, Clauin S, Beaufils S, Wilhelm JM, Boitard C, No&#x000eb;l LH, Velho G, Timsit J. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. <span><span class="ref-journal">Ann Intern Med. </span>2004;<span class="ref-vol">140</span>:510–7.</span> [<a href="/pubmed/15068978" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15068978</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bellann_chantelot.2005.3126">Bellann&#x000e9;-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, Dubois-Laforgue D, Dusselier L, Gautier JF, Jadoul M, Laloi-Michelin M, Jacquesson L, Larger E, Louis J, Nicolino M, Subra JF, Wilhem JM, Young J, Velho G, Timsit J. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. <span><span class="ref-journal">Diabetes. </span>2005;<span class="ref-vol">54</span>:3126–32.</span> [<a href="/pubmed/16249435" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16249435</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.besser.2011.607">Besser RE, Ludvigsson J, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes. <span><span class="ref-journal">Diabetes Care. </span>2011;<span class="ref-vol">34</span>:607–9.</span> [<a href="/pmc/articles/PMC3041191/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3041191</span></a>] [<a href="/pubmed/21285386" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21285386</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.boesgaard.2010.42">Boesgaard TW, Pruhova S, Andersson EA, Cinek O, Obermannova B, Lauenborg J, Damm P, Bergholdt R, Pociot F, Pisinger C, Barbetti F, Lebl J, Pedersen O, Hansen T. Further evidence that mutations in INS can be a rare cause of maturity-onset diabetes of the young (MODY). <span><span class="ref-journal">BMC Med Genet. </span>2010;<span class="ref-vol">11</span>:42.</span> [<a href="/pmc/articles/PMC2848224/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2848224</span></a>] [<a href="/pubmed/20226046" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20226046</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bonnefond.2012.e37423">Bonnefond A, Philippe J, Durand E, Dechaume A, Huyvaert M, Montagne L, Marre M, Balkau B, Fajardy I, Vambergue A, Vatin V, Delplanque J, Le Guilcher D, De Graeve F, Lecoeur C, Sand O, Vaxillaire M, Froguel P. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. <span><span class="ref-journal">PLoS One. </span>2012;<span class="ref-vol">7</span>:e37423.</span> [<a href="/pmc/articles/PMC3372463/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3372463</span></a>] [<a href="/pubmed/22701567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22701567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.borowiec.2009.14460">Borowiec M, Liew CW, Thompson R, Boonyasrisawat W, Hu J, Mlynarski WM, El Khattabi I, Kim SH, Marselli L, Rich SS, Krolewski AS, Bonner-Weir S, Sharma A, Sale M, Mychaleckyj JC, Kulkarni RN, Doria A. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2009;<span class="ref-vol">106</span>:14460–5.</span> [<a href="/pmc/articles/PMC2732833/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2732833</span></a>] [<a href="/pubmed/19667185" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19667185</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bosma.2015.1385">Bosma AR, Rigter T, Weinreich SS, Cornel MC, Henneman L. A genetic diagnosis of maturity-onset diabetes of the young (MODY): experiences of patients and family members. <span><span class="ref-journal">Diabet Med. </span>2015;<span class="ref-vol">32</span>:1385–92.</span> [<a href="/pubmed/25763774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25763774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.bowman.2012.123">Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, Hattersley AT, Ellard S. Heterozygous ABCC8 mutations are a cause of MODY. <span><span class="ref-journal">Diabetologia. </span>2012;<span class="ref-vol">55</span>:123–7.</span> [<a href="/pubmed/21989597" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21989597</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.brackenridge.2006.405">Brackenridge A, Pearson ER, Shojaee-Moradie F, Hattersley AT, Russell-Jones D, Umpleby AM. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations. <span><span class="ref-journal">Diabetes. </span>2006;<span class="ref-vol">55</span>:405–11.</span> [<a href="/pubmed/16443774" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16443774</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.carmody.2016.703">Carmody D, Naylor RN, Bell CD, Berry S, Montgomery JT, Tadie EC, Hwang JL, Greeley SA, Philipson LH. GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated. <span><span class="ref-journal">Acta Diabetol. </span>2016;<span class="ref-vol">53</span>:703–8.</span> [<a href="/pmc/articles/PMC5016218/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5016218</span></a>] [<a href="/pubmed/27106716" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27106716</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.chakera.2014.1230">Chakera AJ, Spyer G, Vincent N, Ellard S, Hattersley AT, Dunne FP. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort. <span><span class="ref-journal">Diabetes Care. </span>2014;<span class="ref-vol">37</span>:1230–6.</span> [<a href="/pubmed/24550216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24550216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.chakera.2015.1383">Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, Ellard S, Hattersley AT. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. <span><span class="ref-journal">Diabetes Care. </span>2015;<span class="ref-vol">38</span>:1383–92.</span> [<a href="/pubmed/26106223" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26106223</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.chen.2010.3326">Chen YZ, Gao Q, Zhao XZ, Chen YZ, Bennett CL, Xiong XS, Mei CL, Shi YQ, Chen XM. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. <span><span class="ref-journal">Chin Med J (Engl). </span>2010;<span class="ref-vol">123</span>:3326–33.</span> [<a href="/pubmed/21163139" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21163139</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.clissold.2015.102">Clissold RL, Hamilton AJ, Hattersley AT, Ellard S, Bingham C. HNF1B-associated renal and extra-renal disease-an expanding clinical spectrum. <span><span class="ref-journal">Nat Rev Nephrol. </span>2015;<span class="ref-vol">11</span>:102–12.</span> [<a href="/pubmed/25536396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25536396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.clissold.2016.203">Clissold RL, Shaw-Smith C, Turnpenny P, Bunce B, Bockenhauer D, Kerecuk L, Waller S, Bowman P, Ford T, Ellard S, Hattersley AT, Bingham C. Chromosome 17q12 microdeletions but not intragenic HNF1B mutations link developmental kidney disease and psychiatric disorder. <span><span class="ref-journal">Kidney Int. </span>2016;<span class="ref-vol">90</span>:203–11.</span> [<a href="/pmc/articles/PMC4915913/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4915913</span></a>] [<a href="/pubmed/27234567" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27234567</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.clocquet.2000.1856">Clocquet AR, Egan JM, Stoffers DA, Muller DC, Wideman L, Chin GA, Clarke WL, Hanks JB, Habener JF, Elahi D. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene). <span><span class="ref-journal">Diabetes. </span>2000;<span class="ref-vol">49</span>:1856–64.</span> [<a href="/pubmed/11078452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11078452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.colclough.2013.669">Colclough K, Bellann&#x000e9;-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:669–85.</span> [<a href="/pubmed/23348805" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23348805</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.colom.2010.605">Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy. <span><span class="ref-journal">Best Pract Res Clin Endocrinol Metab. </span>2010;<span class="ref-vol">24</span>:605–15.</span> [<a href="/pubmed/20832739" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20832739</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.costa.2000.380">Costa A, Bescos M, Velho G, Chevre J, Vidal J, Sesmilo G, Bellann&#x000e9;-Chantelot C, Froguel P, Casamitjana R, Rivera-Fillat F, Gomis R, Conget I. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families. <span><span class="ref-journal">Eur J Endocrinol. </span>2000;<span class="ref-vol">142</span>:380–6.</span> [<a href="/pubmed/10754480" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10754480</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.decramer.2007.923">Decramer S, Parant O, Beaufils S, Clauin S, Guillou C, Kessler S, Aziza J, Bandin F, Schanstra JP, Bellann&#x000e9;-Chantelot C. Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. <span><span class="ref-journal">J Am Soc Nephrol. </span>2007;<span class="ref-vol">18</span>:923–33.</span> [<a href="/pubmed/17267738" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17267738</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.duboislaforgue.2017.1436">Dubois-Laforgue D, Cornu E, Saint-Martin C, Coste J, Bellann&#x000e9;-Chantelot C, Timsit J, et al.  Diabetes, associated clinical spectrum, long-term prognosis and genotype/phenotype correlations in 201 adult patients with hepatocyte nuclear factor 1 B (HNF1B) molecular defects. <span><span class="ref-journal">Diabetes Care. </span>2017;<span class="ref-vol">40</span>:1436–43.</span> [<a href="/pubmed/28420700" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28420700</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.edghill.2006a.84">Edghill EL, Bingham C, Ellard S, Hattersley AT. Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. <span><span class="ref-journal">J Med Genet. </span>2006a;<span class="ref-vol">43</span>:84–90.</span> [<a href="/pmc/articles/PMC2564507/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564507</span></a>] [<a href="/pubmed/15930087" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15930087</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.edghill.2006b.1301">Edghill EL, Bingham C, Slingerland AS, Minton JA, Noordam C, Ellard S, Hattersley AT. Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. <span><span class="ref-journal">Diabet Med. </span>2006b;<span class="ref-vol">23</span>:1301–6.</span> [<a href="/pubmed/17116179" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17116179</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.edghill.2008a.1034">Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, Shields B, Shepherd MH, Hussain K, Kapoor RR, Malecki M, Macdonald MJ, Stoy J, Steiner DF, Philipson LH, Bell GI. Neonatal Diabetes International Collaborative G, Hattersley AT, Ellard S. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. <span><span class="ref-journal">Diabetes. </span>2008a;<span class="ref-vol">57</span>:1034–42.</span> [<a href="/pubmed/18162506" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18162506</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.edghill.2008b.627">Edghill EL, Oram RA, Owens M, Stals KL, Harries LW, Hattersley AT, Ellard S, Bingham C. Hepatocyte nuclear factor-1beta gene deletions--a common cause of renal disease. <span><span class="ref-journal">Nephrol Dial Transplant. </span>2008b;<span class="ref-vol">23</span>:627–35.</span> [<a href="/pubmed/17971380" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17971380</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.ellard.2008.546">Ellard S, Bellann&#x000e9;-Chantelot C, Hattersley AT, et al.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. <span><span class="ref-journal">Diabetologia. </span>2008;<span class="ref-vol">51</span>:546–53.</span> [<a href="/pmc/articles/PMC2270360/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2270360</span></a>] [<a href="/pubmed/18297260" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18297260</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.ellard.2013.1958">Ellard S, Lango Allen H, De Franco E, Flanagan SE, Hysenaj G, Colclough K, Houghton JA, Shepherd M, Hattersley AT, Weedon MN, Caswell R. Improved genetic testing for monogenic diabetes using targeted next-generation sequencing. <span><span class="ref-journal">Diabetologia. </span>2013;<span class="ref-vol">56</span>:1958–63.</span> [<a href="/pmc/articles/PMC3737433/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3737433</span></a>] [<a href="/pubmed/23771172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23771172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.estalella.2007.538">Estalella I, Rica I, Perez De Nanclares G, Bilbao JR, Vazquez JA, San Pedro JI, Busturia MA, Castano L, Spanish MG. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2007;<span class="ref-vol">67</span>:538–46.</span> [<a href="/pubmed/17573900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17573900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.faguer.2011.768">Faguer S, Decramer S, Chassaing N, Bellann&#x000e9;-Chantelot C, Calvas P, Beaufils S, Bessenay L, Lengele JP, Dahan K, Ronco P, Devuyst O, Chauveau D. Diagnosis, management, and prognosis of HNF1B nephropathy in adulthood. <span><span class="ref-journal">Kidney Int. </span>2011;<span class="ref-vol">80</span>:768–76.</span> [<a href="/pubmed/21775974" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21775974</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.fajans.2010.7">Fajans SS, Bell GI, Paz VP, Below JE, Cox NJ, Martin C, Thomas IH, Chen M. Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60. <span><span class="ref-journal">Transl Res. </span>2010;<span class="ref-vol">156</span>:7–14.</span> [<a href="/pmc/articles/PMC2904650/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2904650</span></a>] [<a href="/pubmed/20621032" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20621032</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.fajans.2001.971">Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. <span><span class="ref-journal">N Engl J Med. </span>2001;<span class="ref-vol">345</span>:971–80.</span> [<a href="/pubmed/11575290" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11575290</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.fernandezzapico.2009.36482">Fernandez-Zapico ME, Van Velkinburgh JC, Gutierrez-Aguilar R, Neve B, Froguel P, Urrutia R, Stein R. MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:36482–90.</span> [<a href="/pmc/articles/PMC2794764/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2794764</span></a>] [<a href="/pubmed/19843526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19843526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.ferr_.2013.4089">Ferr&#x000e8; S, Bongers EM, Sonneveld R, Cornelissen EA, Van Der Vlag J, Van Boekel GA, Wetzels JF, Hoenderop JG, Bindels RJ, Nijenhuis T. Early development of hyperparathyroidism due to loss of PTH transcriptional repression in patients with HNF1beta mutations? <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2013;<span class="ref-vol">98</span>:4089–96.</span> [<a href="/pubmed/23979948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23979948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.frayling.1997.720">Frayling TM, Bulamn MP, Ellard S, Appleton M, Dronsfield MJ, Mackie AD, Baird JD, Kaisaki PJ, Yamagata K, Bell GI, Bain SC, Hattersley AT. Mutations in the hepatocyte nuclear factor-1alpha gene are a common cause of maturity-onset diabetes of the young in the U.K. <span><span class="ref-journal">Diabetes. </span>1997;<span class="ref-vol">46</span>:720–5.</span> [<a href="/pubmed/9075818" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9075818</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.froguel.1993.697">Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, et al.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. <span><span class="ref-journal">N Engl J Med. </span>1993;<span class="ref-vol">328</span>:697–702.</span> [<a href="/pubmed/8433729" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8433729</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.garin.2008.873">Garin I, Rica I, Estalella I, Oyarzabal M, Rodriguez-Rigual M, San Pedro JI, Perez-Nanclares G, Fernandez-Rebollo E, Busturia MA, Castano L, Perez De Nanclares G, Spanish MG. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. <span><span class="ref-journal">Clin Endocrinol (Oxf). </span>2008;<span class="ref-vol">68</span>:873–8.</span> [<a href="/pubmed/18248649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18248649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.gragnoli.2001.1326">Gragnoli C, Cockburn BN, Chiaramonte F, Gorini A, Marietti G, Marozzi G, Signorini AM. Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase. <span><span class="ref-journal">Diabetologia. </span>2001;<span class="ref-vol">44</span>:1326–9.</span> [<a href="/pubmed/11692182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11692182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.guenat.2000.377">Guenat E, Seematter G, Philippe J, Temler E, Jequier E, Tappy L. Counterregulatory responses to hypoglycemia in patients with glucokinase gene mutations. <span><span class="ref-journal">Diabetes Metab. </span>2000;<span class="ref-vol">26</span>:377–84.</span> [<a href="/pubmed/11119017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11119017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.harjutsalo.2010.210">Harjutsalo V, Lammi N, Karvonen M, Groop PH. Age at onset of type 1 diabetes in parents and recurrence risk in offspring. <span><span class="ref-journal">Diabetes. </span>2010;<span class="ref-vol">59</span>:210–4.</span> [<a href="/pmc/articles/PMC2797923/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2797923</span></a>] [<a href="/pubmed/19833881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19833881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.hattersley.2017.769">Hattersley AT, Patel KA. Precision diabetes: learning from monogenic diabetes. <span><span class="ref-journal">Diabetologia. </span>2017;<span class="ref-vol">60</span>:769–77.</span> [<a href="/pmc/articles/PMC5907633/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5907633</span></a>] [<a href="/pubmed/28314945" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28314945</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.heidet.2010.1079">Heidet L, Decramer S, Pawtowski A, Moriniere V, Bandin F, Knebelmann B, Lebre AS, Faguer S, Guigonis V, Antignac C, Salomon R. Spectrum of HNF1B mutations in a large cohort of patients who harbor renal diseases. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2010;<span class="ref-vol">5</span>:1079–90.</span> [<a href="/pmc/articles/PMC2879303/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2879303</span></a>] [<a href="/pubmed/20378641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20378641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.johansson.2011.34593">Johansson BB, Torsvik J, Bjorkhaug L, Vesterhus M, Ragvin A, Tjora E, Fjeld K, Hoem D, Johansson S, Raeder H, Lindquist S, Hernell O, Cnop M, Saraste J, Flatmark T, Molven A, Njolstad PR. Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY): a protein misfolding disease. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:34593–605.</span> [<a href="/pmc/articles/PMC3186416/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3186416</span></a>] [<a href="/pubmed/21784842" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21784842</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.kim.2004.1375">Kim SH, Ma X, Weremowicz S, Ercolino T, Powers C, Mlynarski W, Bashan KA, Warram JH, Mychaleckyj J, Rich SS, Krolewski AS, Doria A. Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. <span><span class="ref-journal">Diabetes. </span>2004;<span class="ref-vol">53</span>:1375–84.</span> [<a href="/pubmed/15111509" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15111509</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.kleinberger.2018.583">Kleinberger JW, Copeland KC, Gandica RG, Haymond MW, Levitsky LL, Linder B, Shuldiner AR, Tollefson S, White NH, Pollin TI. Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. <span><span class="ref-journal">Genet Med. </span>2018;<span class="ref-vol">20</span>:583–90.</span> [<a href="/pmc/articles/PMC5955780/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5955780</span></a>] [<a href="/pubmed/29758564" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29758564</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.kristinsson.2001.2098">Kristinsson SY, Thorolfsdottir ET, Talseth B, Steingrimsson E, Thorsson AV, Helgason T, Hreidarsson AB, Arngrimsson R. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. <span><span class="ref-journal">Diabetologia. </span>2001;<span class="ref-vol">44</span>:2098–103.</span> [<a href="/pubmed/11719843" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11719843</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.liljestr_m.2007.1571">Liljestr&#x000f6;m B, Tuomi T, Isomaa B, Sarelin L, Aktan-Collan K, K&#x000e4;&#x000e4;ri&#x000e4;inen H. Adolescents at risk for MODY3 diabetes prefer genetic testing before adulthood. <span><span class="ref-journal">Diabetes Care. </span>2007;<span class="ref-vol">30</span>:1571–3.</span> [<a href="/pubmed/17351287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17351287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.liu.2013.2609">Liu L, Nagashima K, Yasuda T, Liu Y, Hu HR, He G, Feng B, Zhao M, Zhuang L, Zheng T, Friedman TC, Xiang K. Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes. <span><span class="ref-journal">Diabetologia. </span>2013;<span class="ref-vol">56</span>:2609–18.</span> [<a href="/pmc/articles/PMC5333983/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5333983</span></a>] [<a href="/pubmed/24018988" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24018988</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.lorini.2009.1864">Lorini R, Klersy C, D'annunzio G, Massa O, Minuto N, Iafusco D, Bellann&#x000e9;-Chantelot C, Frongia AP, Toni S, Meschi F, Cerutti F, Barbetti F, et al.  Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. <span><span class="ref-journal">Diabetes Care. </span>2009;<span class="ref-vol">32</span>:1864–6.</span> [<a href="/pmc/articles/PMC2752915/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2752915</span></a>] [<a href="/pubmed/19564454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19564454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.ludvigsson.2012.45">Ludvigsson J, Carlsson A, Forsander G, Ivarsson S, Kockum I, Lernmark A, Lindblad B, Marcus C, Samuelsson U. C-peptide in the classification of diabetes in children and adolescents. <span><span class="ref-journal">Pediatr Diabetes. </span>2012;<span class="ref-vol">13</span>:45–50.</span> [<a href="/pubmed/21910810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21910810</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.malecki.1999.323">Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">23</span>:323–8.</span> [<a href="/pubmed/10545951" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10545951</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.mauvaisjarvis.2004.3151">Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M, Riveline JP, Rajan AS, Kevorkian JP, Zhang S, Vexiau P, German MS. Vaisse C. PAX4 gene variations predispose to ketosis-prone diabetes. <span><span class="ref-journal">Hum Mol Genet. </span>2004;<span class="ref-vol">13</span>:3151–9.</span> [<a href="/pmc/articles/PMC6145178/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6145178</span></a>] [<a href="/pubmed/15509590" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15509590</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.mcdonald.2011a.1028">McDonald TJ, Colclough K, Brown R, Shields B, Shepherd M, Bingley P, Williams A, Hattersley AT, Ellard S. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. <span><span class="ref-journal">Diabet Med. </span>2011a;<span class="ref-vol">28</span>:1028–33.</span> [<a href="/pubmed/21395678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21395678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.mcdonald.2011b.1860">McDonald TJ, Shields BM, Lawry J, Owen KR, Gloyn AL, Ellard S, Hattersley AT. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. <span><span class="ref-journal">Diabetes Care. </span>2011b;<span class="ref-vol">34</span>:1860–2.</span> [<a href="/pmc/articles/PMC3142017/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3142017</span></a>] [<a href="/pubmed/21700917" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21700917</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.meur.2010.653">Meur G, Simon A, Harun N, Virally M, Dechaume A, Bonnefond A, Fetita S, Tarasov AI, Guillausseau PJ, Boesgaard TW, Pedersen O, Hansen T, Polak M, Gautier JF, Froguel P, Rutter GA, Vaxillaire M. Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. <span><span class="ref-journal">Diabetes. </span>2010;<span class="ref-vol">59</span>:653–61.</span> [<a href="/pmc/articles/PMC2828668/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2828668</span></a>] [<a href="/pubmed/20007936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20007936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.molven.2008.1131">Molven A, Ringdal M, Nordbo AM, Raeder H, Stoy J, Lipkind GM, Steiner DF, Philipson LH, Bergmann I, Aarskog D, Undlien DE, Joner G, Sovik O, Bell GI, Njolstad PR, et al.  Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. <span><span class="ref-journal">Diabetes. </span>2008;<span class="ref-vol">57</span>:1131–5.</span> [<a href="/pubmed/18192540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18192540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.montoli.2002.397">Montoli A, Colussi G, Massa O, Caccia R, Rizzoni G, Civati G, Barbetti F. Renal cysts and diabetes syndrome linked to mutations of the hepatocyte nuclear factor-1 beta gene: description of a new family with associated liver involvement. <span><span class="ref-journal">Am J Kidney Dis. </span>2002;<span class="ref-vol">40</span>:397–402.</span> [<a href="/pubmed/12148114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12148114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.neve.2005.4807">Neve B, Fernandez-Zapico ME, Ashkenazi-Katalan V, Dina C, Hamid YH, Joly E, Vaillant E, Benmezroua Y, Durand E, Bakaher N, Delannoy V, Vaxillaire M, Cook T, Dallinga-Thie GM, Jansen H, Charles MA, Clement K, Galan P, Hercberg S, Helbecque N, Charpentier G, Prentki M, Hansen T, Pedersen O, Urrutia R, Melloul D, Froguel P. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic beta cell function. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2005;<span class="ref-vol">102</span>:4807–12.</span> [<a href="/pmc/articles/PMC554843/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC554843</span></a>] [<a href="/pubmed/15774581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15774581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF._stoft.2014.1797">&#x000d8;stoft SH, Bagger JI, Hansen T, Pedersen O, Faber J, Holst JJ, Knop FK, Vilsb&#x000f8;ll T. Glucose-lowering effects and low risk of hypoglycemia in patients with maturity-onset diabetes of the young when treated with a GLP-1 receptor agonist: a double-blind, randomized, crossover trial. <span><span class="ref-journal">Diabetes Care. </span>2014;<span class="ref-vol">37</span>:1797–805.</span> [<a href="/pubmed/24929431" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24929431</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.patel.2016.2094">Patel KA, Oram RA, Flanagan SE, De Franco E, Colclough K, Shepherd M, Ellard S, Weedon MN, Hattersley AT. Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. <span><span class="ref-journal">Diabetes. </span>2016;<span class="ref-vol">65</span>:2094–9.</span> [<a href="/pmc/articles/PMC4920219/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4920219</span></a>] [<a href="/pubmed/27207547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27207547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.pearson.2007.e118">Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, Ellard S, Ferrer J, Hattersley AT. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. <span><span class="ref-journal">PLoS Med. </span>2007;<span class="ref-vol">4</span>:e118.</span> [<a href="/pmc/articles/PMC1845156/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1845156</span></a>] [<a href="/pubmed/17407387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17407387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.pearson.2005.878">Pearson ER, Pruhova S, Tack CJ, Johansen A, Castleden HA, Lumb PJ, Wierzbicki AS, Clark PM, Lebl J, Pedersen O, Ellard S, Hansen T, Hattersley AT. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. <span><span class="ref-journal">Diabetologia. </span>2005;2005;<span class="ref-vol">48</span>:878–85.</span> [<a href="/pubmed/15830177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15830177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.pearson.2001.s101">Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. <span><span class="ref-journal">Diabetes. </span>2001;2001;<span class="ref-vol">50</span> Suppl 1:S101–7.</span> [<a href="/pubmed/11272165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11272165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.pihoker.2013.4055">Pihoker C, Gilliam LK, Ellard S, Dabelea D, Davis C, Dolan LM, Greenbaum CJ, Imperatore G, Lawrence JM, Marcovina SM, Mayer-Davis E, Rodriguez BL, Steck AK, Williams DE, Hattersley AT, et al.  Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2013;<span class="ref-vol">98</span>:4055–62.</span> [<a href="/pmc/articles/PMC3790621/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3790621</span></a>] [<a href="/pubmed/23771925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23771925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.plengvidhya.2007.2821">Plengvidhya N, Kooptiwut S, Songtawee N, Doi A, Furuta H, Nishi M, Nanjo K, Tantibhedhyangkul W, Boonyasrisawat W, Yenchitsomanus PT, Doria A, Banchuin N. PAX4 mutations in Thais with maturity onset diabetes of the young. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2007;<span class="ref-vol">92</span>:2821–6.</span> [<a href="/pubmed/17426099" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17426099</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.poolsup.2014.e109985">Poolsup N, Suksomboon N, Amin M. Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e109985.</span> [<a href="/pmc/articles/PMC4193853/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4193853</span></a>] [<a href="/pubmed/25302493" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25302493</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.prudente.2015.177">Prudente S, Jungtrakoon P, Marucci A, Ludovico O, Buranasupkajorn P, Mazza T, Hastings T, Milano T, Morini E, Mercuri L, Bailetti D, Mendonca C, Alberico F, Basile G, Romani M, Miccinilli E, Pizzuti A, Carella M, Barbetti F, Pascarella S, Marchetti P, Trischitta V, Di Paola R, Doria A. Loss-of-function mutations in APPL1 in familial diabetes mellitus. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">97</span>:177–85.</span> [<a href="/pmc/articles/PMC4571002/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4571002</span></a>] [<a href="/pubmed/26073777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26073777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.raeder.2006.54">Raeder H, Johansson S, Holm PI, Haldorsen IS, Mas E, Sbarra V, Nermoen I, Eide SA, Grevle L, Bjorkhaug L, Sagen JV, Aksnes L, Sovik O, Lombardo D, Molven A, Njolstad PR. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:54–62.</span> [<a href="/pubmed/16369531" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16369531</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.raile.2009.2658">Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Muller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Gruters A. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2009;<span class="ref-vol">94</span>:2658–64.</span> [<a href="/pubmed/19417042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19417042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.rubiocabezas.2014.47">Rubio-Cabezas O, Hattersley AT, Njolstad PR, Mlynarski W, Ellard S, White N, Chi DV, Craig ME. International Society For P, Adolescent D. ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. <span><span class="ref-journal">Pediatr Diabetes. </span>2014;<span class="ref-vol">15</span> Suppl 20:47–64.</span> [<a href="/pubmed/25182307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25182307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.schober.2009.466">Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, Holl RW, et al.  Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. <span><span class="ref-journal">Diabet Med. </span>2009;<span class="ref-vol">26</span>:466–73.</span> [<a href="/pubmed/19646184" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19646184</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.shepherd.2001.417">Shepherd M, Ellis I, Ahmad AM, Todd PJ, Bowen-Jones D, Mannion G, Ellard S, Sparkes AC, Hattersley AT. Predictive genetic testing in maturity-onset diabetes of the young (MODY). <span><span class="ref-journal">Diabet Med. </span>2001;<span class="ref-vol">18</span>:417–21.</span> [<a href="/pubmed/11472455" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11472455</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.shepherd.2003.3191">Shepherd M, Pearson ER, Houghton J, Salt G, Ellard S, Hattersley AT. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. <span><span class="ref-journal">Diabetes Care. </span>2003;<span class="ref-vol">26</span>:3191–2.</span> [<a href="/pubmed/14578267" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14578267</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.shepherd.2016.1879">Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K, Oram RA, Knight B, Hyde C, Cox J, Mallam K, Moudiotis C, Smith R, Fraser B, Robertson S, Greene S, Ellard S, Pearson ER, Hattersley AT, et al.  Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes. <span><span class="ref-journal">Diabetes Care. </span>2016;<span class="ref-vol">39</span>:1879–88.</span> [<a href="/pmc/articles/PMC5018394/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5018394</span></a>] [<a href="/pubmed/27271189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27271189</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.shields.2010.2504">Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? <span><span class="ref-journal">Diabetologia. </span>2010;<span class="ref-vol">53</span>:2504–8.</span> [<a href="/pubmed/20499044" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20499044</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.shields.2012.1265">Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. <span><span class="ref-journal">Diabetologia. </span>2012;<span class="ref-vol">55</span>:1265–72.</span> [<a href="/pmc/articles/PMC3328676/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3328676</span></a>] [<a href="/pubmed/22218698" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22218698</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.silva.2012.225">Silva JC, Fachin DR, Coral ML, Bertini AM. Perinatal impact of the use of metformin and glyburide for the treatment of gestational diabetes mellitus. <span><span class="ref-journal">J Perinat Med. </span>2012;<span class="ref-vol">40</span>:225–8.</span> [<a href="/pubmed/22505499" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22505499</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.spyer.2001.240">Spyer G, Hattersley AT, Sykes JE, Sturley RH, Macleod KM. Influence of maternal and fetal glucokinase mutations in gestational diabetes. <span><span class="ref-journal">Am J Obstet Gynecol. </span>2001;<span class="ref-vol">185</span>:240–1.</span> [<a href="/pubmed/11483936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11483936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.stanik.2014.480">Stanik J, Dusatkova P, Cinek O, Valentinova L, Huckova M, Skopkova M, Dusatkova L, Stanikova D, Pura M, Klimes I, Lebl J, Gasperikova D, Pruhova S. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. <span><span class="ref-journal">Diabetologia. </span>2014;<span class="ref-vol">57</span>:480–4.</span> [<a href="/pubmed/24323243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24323243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.steele.2010.157">Steele AM, Shields BM, Shepherd M, Ellard S, Hattersley AT, Pearson ER. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. <span><span class="ref-journal">Diabet Med. </span>2010;<span class="ref-vol">27</span>:157–61.</span> [<a href="/pubmed/20546258" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20546258</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.steele.2014.279">Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, Hattersley AT. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. <span><span class="ref-journal">JAMA. </span>2014;<span class="ref-vol">311</span>:279–86.</span> [<a href="/pubmed/24430320" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24430320</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.steele.2013.e65326">Steele AM, Wensley KJ, Ellard S, Murphy R, Shepherd M, Colclough K, Hattersley AT, Shields BM. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e65326.</span> [<a href="/pmc/articles/PMC3683003/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3683003</span></a>] [<a href="/pubmed/23799006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23799006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.stoffers.1997.138">Stoffers DA, Ferrer J, Clarke W. LHabener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">17</span>:138–9.</span> [<a href="/pubmed/9326926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9326926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.stride.2005.1751">Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M, Hattersley AT. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. <span><span class="ref-journal">Diabetes Care. </span>2005;<span class="ref-vol">28</span>:1751–6.</span> [<a href="/pubmed/15983330" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15983330</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.stride.2002.207">Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. <span><span class="ref-journal">Ann Med. </span>2002;<span class="ref-vol">34</span>:207–16.</span> [<a href="/pubmed/12173691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12173691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.stride.2014.54">Stride A, Shields B, Gill-Carey O, Chakera AJ, Colclough K, Ellard S, Hattersley AT. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. <span><span class="ref-journal">Diabetologia. </span>2014;<span class="ref-vol">57</span>:54–6.</span> [<a href="/pmc/articles/PMC3855531/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3855531</span></a>] [<a href="/pubmed/24092492" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24092492</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.thanabalasingham.2011.2801">Thanabalasingham G, Shah N, Vaxillaire M, Hansen T, Tuomi T, Gasperikova D, Szopa M, Tjora E, James TJ, Kokko P, Loiseleur F, Andersson E, Gaget S, Isomaa B, Nowak N, Raeder H, Stanik J, Njolstad PR, Malecki MT, Klimes I, Groop L, Pedersen O, Froguel P, Mccarthy MI, Gloyn AL, Owen KR. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. <span><span class="ref-journal">Diabetologia. </span>2011;<span class="ref-vol">54</span>:2801–10.</span> [<a href="/pubmed/21814873" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21814873</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.thomas.2016.332">Thomas ER, Brackenridge A, Kidd J, Kariyawasam D, Carroll P, Colclough K, Ellard S. Diagnosis of monogenic diabetes: 10-year experience in a large multi-ethnic diabetes center. <span><span class="ref-journal">J Diabetes Investig. </span>2016;<span class="ref-vol">7</span>:332–7.</span> [<a href="/pmc/articles/PMC4847886/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4847886</span></a>] [<a href="/pubmed/27330718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27330718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.tuomi.2006.189">Tuomi T, Honkanen EH, Isomaa B, Sarelin L, Groop LC. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. <span><span class="ref-journal">Diabetes Care. </span>2006;<span class="ref-vol">29</span>:189–94.</span> [<a href="/pubmed/16443858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16443858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.uday.2014.327">Uday S, Campbell FM, Cropper J, Shepherd M. Monogenic diabetes and type 1 diabetes mellitus: a challenging combination. <span><span class="ref-journal">Practical Diabetes. </span>2014;<span class="ref-vol">31</span>:327–30.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.ulinski.2006.497">Ulinski T, Lescure S, Beaufils S, Guigonis V, Decramer S, Morin D, Clauin S, Deschenes G, Bouissou F, Bensman A, Bellann&#x000e9;-Chantelot C. Renal phenotypes related to hepatocyte nuclear factor-1beta (TCF2) mutations in a pediatric cohort. <span><span class="ref-journal">J Am Soc Nephrol. </span>2006;<span class="ref-vol">17</span>:497–503.</span> [<a href="/pubmed/16371430" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16371430</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.wright.1993.607">Wright NM, Metzger DL, Borowitz SM, Clarke WL. Permanent neonatal diabetes mellitus and pancreatic exocrine insufficiency resulting from congenital pancreatic agenesis. <span><span class="ref-journal">Am J Dis Child. </span>1993;<span class="ref-vol">147</span>:607–9.</span> [<a href="/pubmed/8506821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8506821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mody-ov.REF.xu.2005.422">Xu JY, Dan QH, Chan V, Wat NM, Tam S, Tiu SC, Lee KF, Siu SC, Tsang MW, Fung LM, Chan KW, Lam KS. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. <span><span class="ref-journal">Eur J Hum Genet. </span>2005;<span class="ref-vol">13</span>:422–7.</span> [<a href="/pubmed/15657605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15657605</span></a>]</div></li></ul></div></div><div id="mody-ov.Chapter_Notes"><h2 id="_mody-ov_Chapter_Notes_">Chapter Notes</h2><div id="mody-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>24 May 2018 (bp) Review posted live</div></li><li class="half_rhythm"><div>5 September 2017 (ddg) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK500456</span><span class="label">PMID: <a href="/pubmed/29792621" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">29792621</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mss/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mkks/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK500456&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK500456/?report=reader">PubReader</a></li><li><a href="/books/NBK500456/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK500456" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK500456" style="display:none" title="Cite this Page"><div class="bk_tt">Naylor R, Knight Johnson A, del Gaudio D. Maturity-Onset Diabetes of the Young Overview. 2018 May 24. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK500456/pdf/Bookshelf_NBK500456.pdf">PDF version of this page</a> (513K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mody-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mody-ov._escape__1_Clinical_Characterist" ref="log$=inpage&amp;link_id=inpage">1. Clinical Characteristics of MODY</a></li><li><a href="#mody-ov._escape__2_Genetic_Causes_of_MOD" ref="log$=inpage&amp;link_id=inpage">2. Genetic Causes of MODY</a></li><li><a href="#mody-ov._escape__3_Evaluation_Strategy_t" ref="log$=inpage&amp;link_id=inpage">3. Evaluation Strategy to Identify the Genetic Cause of MODY in a Proband</a></li><li><a href="#mody-ov._escape__4_Management_of_MODY_Ba" ref="log$=inpage&amp;link_id=inpage">4. Management of MODY Based on Genetic Cause</a></li><li><a href="#mody-ov._escape__5_Risk_Assessment_and_S" ref="log$=inpage&amp;link_id=inpage">5. Risk Assessment and Surveillance of At-Risk Relatives for Early Detection and Treatment of MODY</a></li><li><a href="#mody-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mody-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mody-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=640[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">BLK</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6927[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HNF1A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3651[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PDX1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2645[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GCK</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4760[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">NEUROD1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1056[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CEL</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=8462[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KLF11</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3767[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KCNJ11</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=26060[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">APPL1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6928[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HNF1B</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3172[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HNF4A</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3630[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">INS</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5078[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">PAX4</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4545634" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4545634" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28635922" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Molecular genetics of maturity-onset diabetes of the young].</a><span class="source">[Ter Arkh. 2016]</span><div class="brieflinkpop offscreen_noflow">[Molecular genetics of maturity-onset diabetes of the young].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Voevoda MI, Ivanova AA, Shakhtshneider EV, Ovsyannikova AK, Mikhailova SV, Astrakova KS, Voevoda SM, Rymar OD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ter Arkh. 2016; 88(4):117-124. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301549" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Hyperinsulinism</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Hyperinsulinism<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gillis D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/16917892" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.</a><span class="source">[Hum Mutat. 2006]</span><div class="brieflinkpop offscreen_noflow">Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ellard S, Colclough K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mutat. 2006 Sep; 27(9):854-69. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26226118" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing.</a><span class="source">[J Pediatr Endocrinol Metab. 2015]</span><div class="brieflinkpop offscreen_noflow">Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Anık A, Çatlı G, Abacı A, Sarı E, Yeşilkaya E, Korkmaz HA, Demir K, Altıncık A, Tuhan HÜ, Kızıldağ S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Pediatr Endocrinol Metab. 2015 Nov 1; 28(11-12):1265-71. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27103109" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?</a><span class="source">[Can J Diabetes. 2016]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Searching for Maturity-Onset Diabetes of the Young (MODY): When and What for?<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Timsit J, Saint-Martin C, Dubois-Laforgue D, Bellanné-Chantelot C. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Can J Diabetes. 2016 Oct; 40(5):455-461. Epub 2016 Apr 18.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=29792621" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=29792621" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b6c75f66d18aa1c3533">Maturity-Onset Diabetes of the Young Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Maturity-Onset Diabetes of the Young Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:39:24-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A62EBE041A62100000000075002C3&amp;ncbi_session=CE8A62EBE042B6B1_1872SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK500456%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK500456&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK500456/&amp;ncbi_pagename=Maturity-Onset Diabetes of the Young Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A62EBE042B6B1_1872SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>